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A B S T R A C T
Background
Immunisation is a powerful public health strategy for improving child survival, not only by directly combating key diseases that kill
children but also by providing a platform for other health services. However, each year millions of children worldwide, mostly from
low- and middle-income countries (LMICs), do not receive the full series of vaccines on their national routine immunisation schedule.
This is an update of the Cochrane review published in 2011 and focuses on interventions for improving childhood immunisation
coverage in LMICs.
Objectives
To evaluate the effectiveness of intervention strategies to boost and sustain high childhood immunisation coverage in LMICs.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2016, Issue 4, part of The Cochrane Library.
www.cochranelibrary.com, including the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register
(searched 12May 2016); MEDLINE In-Process andOtherNon-Indexed Citations, MEDLINEDaily andMEDLINE 1946 to Present,
OvidSP (searched 12 May 2016); CINAHL 1981 to present, EbscoHost (searched 12 May 2016); Embase 1980 to 2014 Week 34,
OvidSP (searched 2 September 2014); LILACS, VHL (searched 2 September 2014); Sociological Abstracts 1952 - current, ProQuest
(searched 2 September 2014). We did a citation search for all included studies in Science Citation Index and Social Sciences Citation
Index, 1975 to present; Emerging Sources Citation Index 2015 to present, ISI Web of Science (searched 2 July 2016). We also searched
the two Trials Registries: ICTRP and ClinicalTrials.gov (searched 5 July 2016)
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Selection criteria
Eligible studies were randomised controlled trials (RCT), non-RCTs, controlled before-after studies, and interrupted time series
conducted in LMICs involving children aged from birth to four years, caregivers, and healthcare providers.
Data collection and analysis
We independently screened the search output, reviewed full texts of potentially eligible articles, assessed risk of bias, and extracted data
in duplicate; resolving discrepancies by consensus. We then conducted random-effects meta-analyses and used GRADE to assess the
certainty of evidence.
Main results
Fourteen studies (10 cluster RCTs and four individual RCTs) met our inclusion criteria. These were conducted in Georgia (one study),
Ghana (one study), Honduras (one study), India (two studies), Mali (one study), Mexico (one study), Nicaragua (one study), Nepal
(one study), Pakistan (four studies), and Zimbabwe (one study). One study had an unclear risk of bias, and 13 had high risk of bias. The
interventions evaluated in the studies included community-based health education (three studies), facility-based health education (three
studies), household incentives (three studies), regular immunisation outreach sessions (one study), home visits (one study), supportive
supervision (one study), information campaigns (one study), and integration of immunisation services with intermittent preventive
treatment of malaria (one study).
We found moderate-certainty evidence that health education at village meetings or at home probably improves coverage with three
doses of diphtheria-tetanus-pertussis vaccines (DTP3: risk ratio (RR) 1.68, 95% confidence interval (CI) 1.09 to 2.59). We also found
low-certainty evidence that facility-based health education plus redesigned vaccination reminder cards may improve DTP3 coverage
(RR 1.50, 95% CI 1.21 to 1.87). Household monetary incentives may have little or no effect on full immunisation coverage (RR
1.05, 95% CI 0.90 to 1.23, low-certainty evidence). Regular immunisation outreach may improve full immunisation coverage (RR
3.09, 95% CI 1.69 to 5.67, low-certainty evidence) which may substantially improve if combined with household incentives (RR 6.66,
95% CI 3.93 to 11.28, low-certainty evidence). Home visits to identify non-vaccinated children and refer them to health clinics may
improve uptake of three doses of oral polio vaccine (RR 1.22, 95% CI 1.07 to 1.39, low-certainty evidence). There was low-certainty
evidence that integration of immunisation with other services may improve DTP3 coverage (RR 1.92, 95% CI 1.42 to 2.59).
Authors’ conclusions
Providing parents and other community members with information on immunisation, health education at facilities in combination
with redesigned immunisation reminder cards, regular immunisation outreach with and without household incentives, home visits,
and integration of immunisation with other services may improve childhood immunisation coverage in LMIC. Most of the evidence
was of low certainty, which implies a high likelihood that the true effect of the interventions will be substantially different. There is
thus a need for further well-conducted RCTs to assess the effects of interventions for improving childhood immunisation coverage in
LMICs.
P L A I N L A N G U A G E S U M M A R Y
Interventions that will increase and sustain the uptake of vaccines in low- and middle-income countries
What is the aim of this review?
The aim of this Cochrane review was to evaluate the effect of different strategies to increase the number of children in low-and-middle-
income countries who are vaccinated to prevent infection by a disease. Researchers in Cochrane collected and analysed all relevant
studies to answer this question and found 14 relevant studies.
Do strategies to improve childhood vaccination work?
Giving information about vaccination to parents and community members, handing out specially designed vaccination reminder cards,
offering vaccines through regular immunisation outreach with and without household incentives (rewards), identifying unvaccinated
children through home visits and referring them to health clinics, and integrating vaccination services with other services may lead to
more children getting vaccinated. However, offering parents money to vaccinate their children may not improve vaccination uptake.
Most of these findings were of low-certainty, and we need more well-conducted research in this area.
What was studied in the review?
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Millions of children in low-and-middle-income countries still die from diseases that could have been prevented with vaccines. There
are a number of reasons for this. Governments and others have tried different strategies to increase the number of children vaccinated.
What are the main results of the review?
The review authors found 14 relevant studies from Georgia, Ghana, Honduras, India, Mali, Mexico, Nicaragua, Nepal, Pakistan, and
Zimbabwe. The studies compared people receiving these strategies to people who only received the usual healthcare services. The studies
showed the following:
Giving information and discussing vaccination with parents and other community members at village meetings or at home
probably leads to more children receiving three doses of diphtheria-tetanus-pertussis vaccine (moderate-certainty evidence).
Giving information to parents about the importance of vaccinations during visits to health clinics combined with a specially
designed participant reminder card and integration of vaccination services with other health services may improve the uptake of
three doses of diphtheria-tetanus-pertussis vaccine (low-certainty evidence).
Offering money to parents on the condition that they vaccinate their children may make little or no difference to the number of
children that are fully vaccinated (low-certainty evidence).
Using vaccination outreach teams to offer vaccination to villages on fixed times monthly may improve coverage for full vaccination
(low-certainty evidence).
How up-to-date is this review?
The review authors searched for studies that were published up to May 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Population: children aged < 24 months
Setting: Pakistan (2 studies)
Intervention: health educat ion in the community (2 studies)
Comparison: standard care
Outcomes Anticipated absolute effects (95% CI)* Relative effect
(95%CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Health education
DTP3
(Follow-up: 4-9 months)
577 per 1000 969 per 1000
(629 to 1000)
RR 1.68
(1.09 to 2.59)
1692
(2 studies)3
⊕⊕⊕©
Moderate1,2
*The effect in the ’health education’ group (and its 95%CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the intervent ion (and its 95%
CI).
CI: Conf idence interval;DTP3: 3 doses of diphtheria-tetanus-pertussis containing vaccines; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
’Substant ially dif f erent ’ implies a large enough dif ference that it m ight af fect a decision
1 We rated down by 1 level because we judged the included studies at high risk of bias.
2 We rated down by 1 level because of unexplained heterogeneity of ef fects across studies, P value < 0.00001, I2 = 68%.
3 Andersson 2009; Owais 2011.
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B A C K G R O U N D
Immunisation is a powerful public health tool for improving child
survival, not only by directly combating some of the key dis-
eases and causes of child mortality, but also by providing a plat-
form for broader health services (Andre 2008; Bloom 2011; CDC
1999; Clements 2008; JAMA 2006; Okwo-Bele 2012; Wiysonge
2006). The concerted global effort to use immunisation as a pub-
lic health strategy began when the World Health Organization
(WHO) launched the Expanded Programme on Immunization
(EPI) in 1974, following the successful global smallpox eradica-
tion programme (Wiysonge 2013). When the EPI was launched,
WHO recommended a standard immunisation schedule cover-
ing six basic antigens (i.e. tuberculosis (Bacille Calmette-Guérin
(BCG)), polio, diphtheria, tetanus, pertussis, and measles), which
are generally referred to as traditional EPI vaccines.With the emer-
gence of new vaccines, more killer diseases can be prevented in
infancy and adolescence. These vaccines include (but are not lim-
ited to) hepatitis B, Haemophilus influenzae type b (Hib), human
papilloma virus, pneumococcal conjugate, rotavirus, yellow fever,
meningococcal meningitis A, Japanese encephalitis, and rubella
vaccines (WHO 2012a).
The proportion of children who receive the full series of three
doses of diphtheria-tetanus-pertussis containing vaccines (DTP3)
by 12 months of age is traditionally used as a standard measure
of the programme’s ability to reach the target population, and
is used as an indicator of the overall performance of EPI pro-
grammes (Okwo-Bele 2011; WHO-UNICEF 2009). The tradi-
tional EPI vaccines are estimated to prevent 2.5 million child
deaths annually (mainly frommeasles, pertussis, tetanus, anddiph-
theria), as well as to prevent severe morbidity for millions more
children around the world from devastating diseases such as po-
liomyelitis and tuberculous meningitis (CDC 1999; Liu 2012;
Machingaidze 2013a; Okwo-Bele 2011; Rainey 2011; Wiysonge
2005). However, immunisation has the potential to do more; in-
creasing coverage with existing vaccines, as well as the introduc-
tion and increased uptake of a portfolio of newly available vac-
cines in EPI programmes in low- and middle-income countries
(LMICs), could save the lives of millions more children each year
(Andre 2008; Brown 2011; Chopra 2013;Duclos 2009; Liu 2012;
Machingaidze 2013a; WHO-UNICEF 2009; Wiysonge 2012a).
Despite these huge potentials, the vaccination achievements so far
have been described as ’fragile’, given the outbreaks of some of
these infectious diseases in LMICs (Duclos 2009; SAGE 2015;
Siegfried 2010), and inhigh-income countries (Dubé 2013; SAGE
2015). These outbreaks reflect the existence of communities with
partially vaccinated or unvaccinated children (Dubé 2013; SAGE
2015), which are communities whose herd immunity is not high
enough to stall the transmission of these diseases.
In order to overcome these weaknesses and realise the full potential
of immunisation, the ’Decade of Vaccines Collaboration’ devel-
oped theGlobal VaccineActionPlan (GVAP),whichwas endorsed
by the World Health Assembly in May 2012. The plan envisions
“a world in which all individuals and communities enjoy lives free
from vaccine-preventable diseases”. The mission of the GVAP is
to extend, by 2020 and beyond, the full benefit of immunisation
to all people, regardless of where they are born, who they are, or
where they live (WHO 2012a).
Description of the condition
Global DTP3 coverage hovered around 5% in 1974, when EPI
was launched, and increased very slowly to 17% in 1980 (WHO
2012b). Through the 1980s, WHO and the United Nations
Children Fund (UNICEF) led an aggressive global campaign to
achieve universal childhood immunisation, by vaccinating at least
80% of all children with the six traditional EPI vaccines by 1990
(Machingaidze 2013a; Okwo-Bele 2011). The global DTP3 cov-
erage reached 76% in 1990 (WHO 2015). However, the progress
in LMICs was slow as DTP3 coverage was only 57% in Africa
and 70% in South-East Asia (UNICEF 2015a). Up to 2006, only
27% of LMICs hadDTP3 coverage above the 80% target (Rainey
2011). A significant improvementwas reported in 2007 in LMICs,
particularly in sub-Saharan Africa and South-East Asia although
these two regions did not reach the 80% DTP3 coverage (Duclos
2009). WHO and UNICEF estimated that DTP3 coverage in-
creased to 86% globally in 2014 (WHO 2015).
In spite of this improvement, about 18.7 million children un-
der one year of age were said to be unvaccinated with DTP3
globally in 2014. Close to 70% of these children live in just 10
LMICs in Africa and South-East Asia: Democratic Republic of
Congo, Ethiopia, India, Indonesia, Kenya, Mexico, Nigeria, Pak-
istan, South Africa, and Viet Nam (WHO 2015). As a conse-
quence of this continued failure to reach optimal immunisation
coverage, 1.5 million children die each year from diseases pre-
ventable by vaccines currently recommended byWHO. These in-
clude 476,000 deaths from pneumococcal disease, 453,000 from
rotavirus diarrhoea, 199,000 from Hib, 195,000 from pertussis,
118,000 frommeasles, and 59,000 from neonatal tetanus (WHO
2015). Factors associated with low immunisation coverage are
linked to the health system, healthcare providers, and healthcare
recipients (Bloom 2005; Rainey 2011; Wiysonge 2012b).
Some experts have observed growing concerns about vaccines,
which has influenced vaccine acceptance (Bloom 2005; Dubé
2013; Feemster 2013; Larson 2014). Vaccine acceptance spans a
spectrum from complete rejection to total acceptance (Feemster
2013). Along the spectrum is an emerging phenomenon: vaccine
hesitancy (Larson 2014). The Strategic Advisory Group of Experts
on Immunisation (SAGE) defines vaccine hesitancy as a behaviour
that includes confidence, complacency, and convenience. Accord-
ing to SAGE, vaccine-hesitant people may accept all vaccines but
with concerns, may accept only some vaccines or delay in taking
up vaccines, or may totally reject all vaccines (Larson 2014).
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There are varied reasons for failing to achieve universal coverage in
different settings. Such reasons span from inaccessible services and
poor logistic support, to political instability, including wars and
public perceptions (Bloom 2005). Evidence is required to inform
strategies to reach partially vaccinated and unvaccinated people in
these countries. Such strategies also need to be tailored to local
issues, needs, and conditions.
Description of the intervention
Several experts have highlighted the wide range of issues affect-
ing uptake of vaccines in various settings (Bloom 2005; Dubé
2013; Mills 2005; Munoz 2015). The issues vary between and
within settings due to social, economic, cultural, geographical, po-
litical, and religious factors. Therefore, potential interventions are
also likely to vary across different settings. Based on the findings
from reviews on this, Table 1 presents a matrix of interventions
to address the issues. Broadly, these strategies could include re-
cipient-oriented interventions, for example, recipient recalls and
reminders, health education of clients, teaching recipients skills;
provider-oriented interventions, such as audit and feedback and
chart-based or computerised provider reminders; and health sys-
tem interventions, such as outreach programmes and improved
quality of delivery of care (Lewin 2011). These could be delivered
as single or multi-faceted interventions.
How the intervention might work
The various interventions serve different purposes. Table 1
presents this matrix. Some interventions can be used for both re-
cipients and providers, for example, remind/recall interventions
could target both caregivers and healthcare providers.
Why it is important to do this review
In many LMICs, immunisation coverage is low (WHO 2012b;
UNICEF 2015b), routine immunisation systems are weak (
Machingaidze 2013a), and community knowledge of immunisa-
tion is low (Zipursky 2010). The target of GVAP was to achieve
DTP3 coverage of at least 90% in all countries by 2015.While 129
countries achieved the 90% coverage target by 2014, the 10 coun-
tries with the largest numbers of unimmunised children are all
low-income or lower- to middle-income countries (SAGE 2015;
WHO 2015).
Making well-informed decisions about how best to achieve and
sustain high and equitable immunisation coverage in these coun-
tries will depend partly on decision makers accessing the best sci-
entific evidence about what interventions work, and integrating
this evidence into their national health systems (Lewin 2008).One
previous Cochrane review assessed recipient-oriented reminders
and recalls (Jacobson Vann 2005). The evidence indicated that
reminding people to receive vaccinations through postcards, let-
ters, or telephone calls increased immunisation uptake. This strat-
egy generally relies on setting up an efficient computerised vac-
cination registry or other practice-based information systems to
track clients’ vaccination status and eligibility for recommended
vaccines, and also an efficient communication system to send re-
minders to clients. These technologies are lacking inmany LMICs.
This review examines the effects of strategies that utilise available
resources in LMICs for improving vaccination coverage in the
bid to provide evidence on appropriate strategies to improve and
sustain immunisation coverage in these settings. In addition, it
also explores provider-oriented interventions (Djibuti 2009), and
health system interventions (Brugha 1996), towards improving
immunisation coverage.
This is the first update of the Cochrane review published in 2011
(Oyo-Ita 2011), and complements two other Cochrane reviews
conducted under the auspices of the ’Communicate to Vaccinate’
project (Lewin 2011), which have a worldwide focus and assess
the effects of face-to-face (Kaufman 2013) and community-di-
rected interventions (Saeterdal 2014) to inform or educate about
childhood vaccination. It also complements Jacobson Vann’s re-
view on participant reminder and recall systems to improve immu-
nisation rates (Jacobson Vann 2005) by providing evidence on the
wide range of interventions covering recipients, providers, and the
health system that can be used to improve vaccination coverage.
O B J E C T I V E S
To evaluate the effectiveness of intervention strategies to boost and
sustain high childhood immunisation coverage in LMICs.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included:
1. randomised controlled trials (RCTs), with randomisation at
either individual or cluster level. For cluster RCTs, we only
included those with at least two intervention and two control
clusters.
2. non-randomised controlled trials (nRCTs), with allocation
at either individual or cluster level. We included studies that
allocated by alternation between groups, by the use of birth dates
or weekdays, or by other non-random methods. For cluster trials,
we only included those with at least two intervention and two
control clusters.
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3. interrupted time series studies (ITS) and repeated measures
studies, with a clearly defined time point when the intervention
occurred and at least three data points before and three after the
intervention.
4. controlled before-after (CBA) studies with a minimum of
two intervention and two control sites; comparable timing of the
periods of study for the control and intervention groups; and
comparability of the intervention and control groups on key
characteristics.
We excluded:
CBA studies, cluster RCTs, and nRCTs that had only two study
locations, in accordance with Effective Practice and Organisation
of Care (EPOC) criteria for inclusion of studies (EPOC 2015a).
Types of participants
Studies conducted in LMICs (World Bank 2016) that included:
1. children under five years of age receiving WHO-
recommended vaccines through routine childhood
immunisation services;
2. caregivers of children who were receiving vaccines through
routine childhood immunisation services;
3. healthcare workers administering vaccines through routine
childhood immunisation services;
4. or a combination of these.
For the purposes of this review, we defined routine childhood im-
munisation services as regularly scheduled immunisation services
to children under five years of age, whether these services were
offered at healthcare facilities, at fixed outreach sites, or by mobile
health teams in communities (Machingaidze 2013b).
We limited the review to LMICs because of the continued failure
to meet immunisation target and the weak routine immunisation
system in this setting.
Types of interventions
Interventions
1. Recipient-oriented interventions, for example:
i) interventions to improve communication about
childhood immunisation, including to (Willis 2013):
a) inform or educate;
b) remind or recall;
c) teach skills;
d) provide support;
e) facilitate decision making;
f ) enable communication;
g) enhance community ownership;
h) meet vaccination requirement for school entry;
i) use recipient incentives.
2. Provider-oriented interventions, for example:
i) any intervention to reduce missed opportunities for
childhood vaccination (e.g. audit and feedback, provider
reminders, supportive supervision);
ii) health education, training, and refresher courses for
providers.
3. Health system interventions, for example:
i) interventions to improve the quality of services, such
as provision of a reliable cold chain system, provision of
transport for vaccination, vaccine stock management;
ii) outreach programmes (e.g. school immunisation
outreach programmes, door-to-door canvassing (channeling);
iii) expanded services (e.g. extended hours for
immunisation);
iv) increases in budgets for immunisation;
v) integration of immunisation services with other
services;
vi) plans of action for immunisation coverage and disease
reduction goals.
4. Multi-faceted (i.e. any combination of the above categories
of ) interventions.
5. Other interventions intended to improve immunisation
coverage.
Comparisons
1. Standard immunisation practices in the study setting.
2. Different interventions, or similar interventions
implemented with different degrees of intensity.
Types of outcome measures
Primary outcomes
1. Proportion of children who received DTP3 by one year of
age.
2. Proportion of children who received all recommended
vaccines by two years of age.
Secondary outcomes
1. Proportion of children who received the vaccine under
study.
2. Number of children under five years of age fully immunised
with all scheduled vaccines.
3. Occurrence of vaccine preventable diseases.
4. Costs of the intervention.
5. Attitudes of caregivers and clients towards immunisation.
6. Adverse events following immunisation (AEFI).
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Search methods for identification of studies
Electronic searches
We placed no language or date restrictions on the search strategy.
We translated theMEDLINE (Ovid) search strategy into the other
databases using the appropriate controlled vocabulary.
We searched the following electronic databases on the dates indi-
cated:
1. Cochrane Central Register of Controlled Trials
(CENTRAL), 2016, Issue 4, including the Cochrane EPOC
Group Specialized Register (searched 12 May 2016)
2. MEDLINE In-Process and Other Non-Indexed Citations,
MEDLINE Daily and MEDLINE 1946 to Present, OvidSP
(searched 12 May 2016)
3. CINAHL 1981 to present, EbscoHost (searched 12 May
2016)
4. Embase 1980 to 2014 Week 34, OvidSP (searched 2
September 2014)
5. LILACS (VHL) (searched 2 September 2014)
6. Sociological Abstracts 1952 - current, ProQuest (searched 2
September 2014)
On 12 May 2016 we searched only CENTRAL, MEDLINE, and
CINAHL. Embase, Socioligical Abstracts, and LILACs were not
searched for the following reasons. All 14 studies included in the
review after the 2014 searches are indexed in CENTRAL, and 11
of the 14 studies are indexed in MEDLINE. The three studies not
indexed in MEDLINE are not indexed in EMBASE. None of the
14 studies are indexed in Sociological Abstarcts. The three studies
not indexed in MEDLINE are not indexed in LILACS. All of the
search strategies are in Appendix 1.
Searching other resources
We also searched the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Abstracts of Reviews of Effectiveness
(DARE) for related reviews. We searched the reference lists of rel-
evant reviews for potentially eligible studies (Batt 2004; Bordley
2000; Glenton 2011; Harvey 2015; Jacobson Vann 2005; Johri
2015b; Kaufman 2013; Kendrick 2000; Lagarde 2009a; Lagarde
2009b; Pegurri 2005; Ryman 2008; Saeterdal 2014). We also
searched the reference lists of included studies for potentially eli-
gible studies. We did a citation search for all included studies in
Science Citation Index and Social Sciences Citation Index, 1975
to present; Emerging Sources Citation Index 2015 to present, ISI
Web of Science (searched 2 July 2016)
We searched the following Trials Registries
· International Clinical Trials Registry Platform (ICTRP),
Word Health Organization (WHO) http://www.who.int/ictrp/
en/ (searched 5 July 2016)
·ClinicalTrials.gov, USNational Institutes of Health (NIH) http:/
/clinicaltrials.gov/ (searched 5 July 2016)
Data collection and analysis
Selection of studies
At least two review authors independently screened the titles and
abstracts of papers identified in the search output for potentially
eligible studies. We retrieved full texts of potentially eligible stud-
ies for further assessment, and two review authors independently
applied the inclusion criteria to these publications. We resolved
disagreements about the inclusion of studies through discussion
and consensus between the two review authors; and involved a
third review author if the disagreement was not resolved. We ob-
tained methodological advice from the EPOC editorial base for
unresolved issues. The Characteristics of excluded studies presents
reasons for excluding studies.
Data extraction and management
All review authors developed and reviewed a data extraction form.
Two review authors independently carried out data extraction and
risk of bias assessment. We resolved disagreements in data extrac-
tion by consensus between the two review authors, with arbitra-
tion by a third author as required. The data extracted into an Excel
spreadsheet included the following:
1. Setting of the study.
2. Type of study: distinguishing between individual RCTs,
cluster RCTs, nRCTs, CBA studies, and ITS studies.
3. Type of participants: children, caregivers, and providers.
4. Type of interventions: categorised into participant and
community, provider, health system, and multi-faceted.
5. Types of outcomes measured: data on outcome measures
such as proportion of children immunised with different
antigens based on the different interventions.
Assessment of risk of bias in included studies
Two review authors applied the EPOC risk of bias criteria for
RCTs, nRCTs, CBAs, and ITS studies to determine the risk of bias
in included studies (EPOC 2015b). We resolved disagreements
by discussion and consensus, with arbitration by a third review
author as required.
Each criterion was scored as ’low risk’, ’unclear risk’, or ’high risk’
(Characteristics of included studies table). Figure 1 and Figure 2
present the risk of bias for each included study. We considered a
study as having a ’low risk of bias’ if all criteria prescribed by EPOC
were scored as ’Yes’; ’unclear risk of bias’ if one or more criteria
were scored as ’Unclear’; and ’high risk of bias’ if one or more key
criteria scored as ’No’. The key criteria included allocation conceal-
ment, completeness of outcome data, blinding of outcome asses-
sors, and protection against contamination for RCTs and NRCTs;
and independence of intervention from other changes, possibility
of intervention affecting data collection, completeness of outcome
data, and blinding of outcome assessors for ITS studies.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
Measures of treatment effect
We used the risk ratio (RR) for dichotomous data. We planned to
calculate themeandifference (MD) for costs and any other analysis
of continuous data but none of the included studies reported these
types of data. We reported 95% confidence intervals (CI) for all
measures.
Unit of analysis issues
We included cluster RCTs in the meta-analysis after making ad-
justments for design effect using standard procedures (Rao 1992),
and the formula: design effect = 1 + (m - 1)r, where m was the
mean cluster size and r was the intra-cluster correlation coefficient
(ICC). Using data from Andersson 2009, we calculated the ICC
for measles to be 0.25 and for DTP3 to be 0.14. We used this
to estimate the adjusted standard error for the data of Andersson
2009; Banerjee 2010; Barham 2005; Brugha 1996; Dicko 2011;
Maluccio 2004; and Robertson 2013 none of the data from the
cluster RCTs were appropriately adjusted for clustering. We en-
tered data from Dicko 2011 as absolute figures into Review Man-
ager 5 (RevMan 2014) and calculated RRs; consequently, we ap-
plied the ICC to adjust for cluster effect.
Dealing with missing data
We contacted the authors of two studies to obtain missing data
(Djibuti 2009;Morris 2004).Morris 2004 responded, andwe used
the additional data to estimate the ICC for the study. Additional
data received included the absolute number of events in each arm
of the study for the Morris 2004 study; we estimated the ICC for
mumps, measles, rubella (MMR) (0.013) and DTP1 (0.0377) for
the post-intervention assessment only. We then used the ICC to
adjust the standard error for the two outcomes from this study
that we included in this review.
Five studies followed up the same set of participants post-inter-
vention (Bolam 1998; Brugha 1996; Owais 2011; Usman 2009;
Usman 2011). There were no missing data in three of these studies
(Brugha 1996;Usman 2009;Usman 2011), andmissing data were
minimal (2%) in one study (Owais 2011) and high (greater than
20%) in Bolam 1998 study. Robertson 2013 accounted for miss-
ing data and applied intention-to-treat analysis. The remaining
studies had independent sampling at pre- and post-intervention
stages so missing data from loss to follow-up was not applicable
in these studies (Andersson 2009; Banerjee 2010; Barham 2005;
Dicko 2011; Djibuti 2009; Maluccio 2004; Morris 2004; Pandey
2007).
Assessment of heterogeneity
We reviewed heterogeneity in the setting, interventions, and out-
comes of included studies in order tomake a qualitative assessment
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of the extent to which the included studies were similar to each
other. We examined the forest plots visually to assess the levels of
heterogeneity. We considered meta-analyses with a P value for the
Chi2 test of less than 0.1 to have considerable statistical hetero-
geneity. We used an I2 statistic of 50% or more to quantity the
level of statistical heterogeneity.We planned to subject such meta-
analyses to subgroup analyses for investigation of heterogeneity
(see Subgroup analysis and investigation of heterogeneity). How-
ever, due to the paucity of data, such subgroup analysis was not
feasible.
Assessment of reporting biases
Test for asymmetry with a funnel plot was not feasible because the
number of included studies for meta-analysis was too few.
Data synthesis
We planned to pool data from studies with similar interven-
tions (participant or community, provider, health system, multi-
faceted), grouped by study design (RCTs, nRCTs, CBAs, ITS stud-
ies), in a meta-analysis using the random-effects model. For stud-
ies that reported only effect estimates with the measures of uncer-
tainty, butwithout numbers of participants and numbers of events,
we planned to analyse the effect estimate using the generic inverse
variance approach. ITS studies were to be reported as changes in
level and slope. We selected the random-effects model as the de-
fault procedure in the analysis due to heterogeneity, based on the
assumption of random distribution of the variation in the effects
of interventions in the different studies.
Subgroup analysis and investigation of heterogeneity
We planned to explore anticipated differences in the impact of
interventions across settings and mode of delivery of the interven-
tions. We planned the following subgroup analyses:
1. Setting of the study (rural, urban).
2. Individual or group intervention.
3. Single or multi-faceted/integrated intervention.
4. Conditional or non-conditional incentive.
5. Facility- or community-based intervention.
Due to paucity of data subgroup analysis was only possible for
facility- versus community-based health education.
Sensitivity analysis
We planned to perform a sensitivity analysis based on risk of bias
and missing data if we found sufficient data: however, available
data were insufficient to perform this analysis. Due to diversity
in the reported outcomes across studies, we pooled data for only
three interventions, namely health education for DTP3, health
education plus redesigned cards for DTP3, and monetary incen-
tive for full immunisation. There was heterogeneity in the pooled
data on health education and health education plus redesigned
card interventions. This could be attributed to the high risk of bias
of included studies and the difference in the mode of delivery of
the interventions.
Assessment of certainty of evidence
We assessed certainty of the evidence using GRADE (Grading of
Recommendations, Assessment, Development, and Evaluation)
(Guyatt 2008; Higgins 2011). We entered data for key interven-
tions into the Grade Profiler and graded the certainty of evidence
for the outcomes as ’high’, ’moderate’, ’low’, and ’very low’, de-
fined as follows:
High certainty: this research provided a very good indication of
the likely effect. The likelihood that the effect will be substantially
different was low.
Moderate certainty: this research provided a good indication of
the likely effect. The likelihood that the effect will be substantially
different was moderate.
Low certainty: this research provided some indication of the likely
effect.However, the likelihood that it will be substantially different
was high.
Very low certainty: this research did not provide a reliable indi-
cation of the likely effect. The likelihood that the effect will be
substantially different was very high.
’Substantially different’ implies a large enough difference that it
might affect a decision.
R E S U L T S
Description of studies
Results of the search
The electronic and supplementary searches yielded 10158 records,
after removing duplicates. Following screening of titles and ab-
stracts, we selected 79 studies for full text screening; 14 were el-
igible for inclusion in the review; we excluded 54, and 11 stud-
ies are awaiting assessment (Figure 3). In this update, we added
an additional eight studies (Banerjee 2010; Barham 2005; Bolam
1998;Dicko 2011;Maluccio 2004;Owais 2011; Robertson 2013;
Usman 2011) to the six studies included in the first version of the
review (Oyo-Ita 2011).
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Figure 3. Study flow diagram.
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Included studies
Study design and setting
Fourteen studies met the inclusion criteria (Andersson 2009;
Banerjee 2010; Barham 2005; Bolam 1998; Brugha 1996; Dicko
2011; Djibuti 2009; Maluccio 2004; Morris 2004; Owais 2011;
Pandey 2007; Robertson 2013; Usman 2009; Usman 2011).
Ten studies were cluster RCTs (Andersson 2009; Banerjee 2010;
Barham 2005; Brugha 1996;Dicko 2011;Djibuti 2009;Maluccio
2004; Morris 2004; Pandey 2007; Robertson 2013). Of these,
Brugha 1996 and Robertson 2013 were matched cluster RCTs
and Djibuti 2009 used stratified cluster sampling. The remaining
four studies were individually randomised controlled trials (Bolam
1998; Owais 2011; Usman 2009; Usman 2011). The unit of anal-
ysis was the participant in all the studies except Morris 2004 and
Pandey 2007, in which household was the unit of analysis. There
were no nRCTs, CBAs, or ITS studies among the included studies.
Location of studies
The studies were conducted in Georgia (Djibuti 2009), Ghana
(Brugha 1996), Honduras (Morris 2004), India (Banerjee 2010;
Pandey 2007), Mali (Dicko 2011), Nepal (Bolam 1998), Pakistan
(Andersson 2009;Owais 2011;Usman 2009;Usman 2011),Mex-
ico (Barham 2005), Nicaragua (Maluccio 2004), and Zimbabwe
(Robertson 2013).
Participants
Owais 2011 recruited children aged less than six weeks; Usman
2009 and Usman 2011 included children registering for DTP1
(which the authors noted was given at six weeks of age in the
country); Banerjee 2010 included children aged from birth to six
months; Dicko 2011 recruited children aged from birth to 23
months; Andersson 2009 included children aged 12 to 23months;
andBrugha 1996 studied childrenwhowere aged 12 to18months.
Barham2005 studied children aged12 to18months andMaluccio
2004 studied children aged from birth to 30 months. Robertson
2013 studied children under the age of five years. Participants
in four studies were adults: primary healthcare workers (Djibuti
2009), the general population (Pandey 2007), pregnant women
(Morris 2004), and postpartumwomen (Bolam 1998). The adults
were targeted with a view to improving childhood immunisation
coverage.
Outcomes
Outcome measurements were similar at baseline between inter-
vention and control groups except for Dicko 2011; the researchers
did not adjust for this baseline difference.
Sampling
Five studies carried out independent sampling in the pre- and
post-intervention periods (Andersson 2009; Banerjee 2010;Dicko
2011; Djibuti 2009; Maluccio 2004). Morris 2004 and Barham
2005 had independent sampling for each outcome and for each
armof the intervention groups. Seven studies followed up the same
participants at pre- and post-intervention (Bolam 1998; Brugha
1996; Owais 2011; Pandey 2007; Robertson 2013; Usman 2009;
Usman 2011).
Interventions
The individual studies evaluated interventions as follows:
1. Recipient-oriented interventions.
i) Health education on the importance of completion of
the immunisation schedule, and on other immunisation-related
issues.
ii) Health education plus ’reminder-type’ immunisation
cards to remind caregivers of their next immunisation
appointment.
iii) Easy to understand pictorial card using simple
language to explain how vaccines save children’s lives, and where
the vaccination centre was located.
iv) Monetary incentives to increase demand for preventive
healthcare interventions.
a) Conditional and unconditional cash transfers to
encourage clinic attendance for child development services.
2. Provider-oriented interventions.
i) Training of immunisation district managers, together
with supportive supervision and audit and feedback regarding
solving problems on immunisation services.
ii) Training of health providers on valid doses for
vaccination.
3. Health system-oriented interventions.
i) Home visits to identify unimmunised children.
ii) Regular immunisation outreach sessions in the villages
to ensure regular availability of immunisation services.
iii) Integration of immunisation with intermittent
preventive treatment of malaria to support child health
interventions.
4. Multi-faceted interventions.
i) Health system plus provider-oriented interventions.
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ii) Health system plus provider-oriented plus recipient-
oriented interventions.
iii) Reach every district approach: a combination of
planning, outreach, community mobilisation, supportive
supervision, and monitoring.
See below for more detail of these interventions.
Recipient-oriented interventions
Health education
Health education interventions included evidence-based discus-
sions in the community on the prevalence of measles among chil-
dren and the importance of childhood immunisation in Pakistan
(Andersson 2009); an information campaign in India that involved
presentation of audiotape messages, and distribution of posters
and leaflets in the community (Pandey 2007); and three targeted
pictorial messages regarding vaccines administered by trained lay/
community health workers at the mothers’ homes in Pakistan
(Owais 2011). The first key pictorial message highlighted how
vaccines save children’s lives. The secondmessage provided logistic
information about the address and location of the local vaccina-
tion centres. The third key message emphasised the significance
of retaining immunisation cards, and the role they could play at
the time of the child’s school admissions. A copy of these pictorial
messages was left with the mother. Three studies in Nepal and
Pakistan provided health education in the health facility on the
importance of completion of the immunisation schedule (Bolam
1998; Usman 2009; Usman 2011). In the Bolam 1998 study in
Nepal, one arm had only one-to-one facility-based education after
delivery and before discharge from the hospital, the second arm
had only a one-to-one education session in the mothers’ homes
threemonths after delivery, while the third arm included both one-
to-one health education immediately after birth and threemonths
later. The last arm was included in the study.
Monetary incentives
Barham 2005 inMexico combined conditional cash transfers with
free provision of health and education services. The conditions for
the cash transfer included receiving regular immunisation, growth
monitoring, mother’s attendance at health, hygiene, and nutri-
tion education programs; and nutritional supplements for chil-
dren aged from birth to two years and for pregnant and lactating
mothers.
In Nicaragua, one of the interventions in Maluccio 2004 was
a monthly “food security” cash transfer (“bono alimentario” =
USD224 per year = 13% of total amount of household expen-
ditures in beneficiary households before the programme), condi-
tional on attendance at monthly health educational workshops,
on bringing their children aged under five for free scheduled pre-
ventive childcare appointments (which include the provision of
anti-parasites drugs, and vitamins and iron supplements), on hav-
ing up-to-date vaccination, and on adequate weight gain. Morris
2004 assessed the effect of withdrawing monetary vouchers if the
mothers were not up-to-date with routine antenatal care and well-
child preventive health care, and if the child did not attend school
regularly.
Robertson 2013 in Zimbabwe compared two interventions. Both
included a cash transfer of USD18 per household and USD4 per
child every two months. In one of the arms, the transfer was on
the condition that: those aged below 18 years with no birth certifi-
cate applied for one within three months; children aged under five
years were up-to-date with immunisation, and attended growth
monitoring clinics; children aged from six to 17 years had 90%
monthly attendance at school; and a representative of every house-
hold attended two-thirds of local parenting skills classes. In the
second arm there were no conditions attached to the cash transfer.
Health Education plus ’reminder-type’ immunisation card
Two studies evaluated an enlarged immunisation card, designed
to remind mothers of immunisation appointments (Usman 2009;
Usman 2011).
Provider-oriented interventions
Interventions targeting providers in Georgia included training in
continuous supportive supervision, development of supportive su-
pervision guidelines, and tools for immunisation district managers
(Djibuti 2009).
Health system interventions
Home visits
Brugha 1996 reported on the effects of home visits on childhood
immunisation in Ghana: undergraduate students conducted the
home visits, which aimed to identify non-immunised children and
refer them for immunisation at the health centre. Another review
considered these students to be lay/community health workers
(Glenton 2011).
Integration of services
The Dicko 2011 study assessed the effects of integrating immuni-
sation service delivery with intermittent preventive treatment of
malaria in infants.
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Regular immunisation outreach sessions
One study assessed the effects of regular monthly immunisation
camps (Banerjee 2010). This intervention focused on ensuring
the regular availability of immunisation services. It consisted of a
mobile immunisation team, including a nurse and assistant, who
conducted monthly immunisation camps in villages. The camp
was held on a fixed date and time every month in each village.
Multi-faceted (health system plus provider interventions)
One arm of the Morris 2004 study set up quality assurance (QA)
teams in rural Honduras in health centres allocated to the inter-
vention. The team, with wide representation from the local com-
munities, was trained on QAmethods. They produced work plans
that could include minor structural repairs to health centres and
the purchase of equipment, materials, and essential drugs. This
arm of the study also included training of lay nutrition promot-
ers who conducted monthly weighing of children aged less than
two years and counselling of mothers. This intervention was not
carried out as stipulated in the protocol, as only 17% of the total
budget for the intervention was disbursed.
QA trainingwas limited to only the introduction to theQA course.
It was not clear what the composition of the QA course was.
However, QA usually aims at ensuring that standards are met.
This assures the service users of the quality of services and may
encourage increased utilisation of services.
One arm of the study by Banerjee and colleagues assessed a regu-
lar once-monthly immunisation camp complemented with small
material incentives in India (Banerjee 2010). The investigators of-
fered parents 1 kg of raw lentils per immunisation administered
and a set of “thalis” (metal plates used for meals) on completion
of a child’s full immunisation. The value of the lentils was about
USD1, equivalent to three-quarters of one day’s wage, and the
value of the “thalis” was about USD2.00
Comparison
The comparison groups received routine care in five studies
(Andersson 2009; Brugha 1996; Dicko 2011; Morris 2004;
Usman 2009). The study authors did not state what comprised
routine care. The comparison group received no interventions in
seven studies (Banerjee 2010; Barham 2005; Bolam 1998; Djibuti
2009; Maluccio 2004; Pandey 2007; Usman 2011). In the Owais
2011 study, the comparison group received verbal general mes-
sages (while the intervention group received three targeted picto-
rial messages). In the Robertson 2013 study, the comparison group
received unconditional cash transfers.
Outcomes
Eleven studies provided data on the proportion of the target pop-
ulation that was fully immunised (by age) by the recommended
vaccine (Andersson 2009; Banerjee 2010; Bolam 1998; Brugha
1996; Dicko 2011; Djibuti 2009; Maluccio 2004; Owais 2011;
Robertson 2013; Usman 2009; Usman 2011). Other outcomes
reported were: DTP3 coverage (Andersson 2009; Bolam 1998;
Dicko 2011; Owais 2011; Usman 2009; Usman 2011); percent-
age change in immunisation coverage over time (Andersson 2009;
Morris 2004); tetanus toxoid coverage in children (Pandey 2007);
received at least one vaccine (Pandey 2007); oral polio coverage
(Brugha 1996); completion of schedule (Brugha 1996); cost of
the intervention (Andersson 2009); and coverage for tuberculosis
and measles vaccines (Barham 2005).
Nine studies measured outcomes at the participant level (
Andersson 2009; Banerjee 2010; Bolam 1998; Brugha 1996;
Dicko 2011; Djibuti 2009; Owais 2011; Usman 2009; Usman
2011); while five studies measured the outcome at the household
level (Barham 2005; Maluccio 2004; Morris 2004; Pandey 2007;
Robertson 2013)..
Follow-up
The period of follow-up varied between studies from threemonths
to four years. Two studies had no loss to follow-up (Usman 2009;
Usman 2011), three studies had 2% to 5% loss to follow-up (
Morris 2004; Owais 2011; Pandey 2007), and two studies had loss
to follow-up of 17% or more (Banerjee 2010; Bolam 1998). Five
studies had two independent samples for pre- and post- follow-
up (Andersson 2009; Barham 2005; Dicko 2011; Djibuti 2009;
Maluccio 2004), while Brugha 1996 did not account for loss to
follow-up. Robertson 2013 had less than 4% loss to follow-up.
Excluded studies
We excluded 54 potentially studies for reasons provided in the
Characteristics of excluded studies table.
Eleven studies are awaiting assessment of their eligibility (see
Characteristics of studies awaiting classification table)
Risk of bias in included studies
Based on our pre-defined criteria, we assessed no study as having a
low risk of bias; one study had unclear risk of bias (Owais 2011),
and the remaining 13 studies had high risk of bias.
Allocation
The risk of selection bias (allocation concealment) was low for
three studies (Andersson 2009; Banerjee 2010; Dicko 2011), un-
clear for seven studies (Bolam 1998; Brugha 1996; Djibuti 2009;
Owais 2011; Pandey 2007; Usman 2009; Usman 2011), and high
for four studies (Barham 2005; Maluccio 2004; Morris 2004;
Robertson 2013).
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Blinding
Risk of bias in relation to blinding of participants, personnel,
and outcome assessments was low for six studies (Andersson
2009; Banerjee 2010; Bolam 1998; Owais 2011; Pandey 2007;
Robertson 2013), unclear for three studies (Dicko 2011; Djibuti
2009; Morris 2004), and high for five studies (Barham 2005;
Brugha 1996; Maluccio 2004; Usman 2009; Usman 2011).
Incomplete outcome data
The risk of attrition bias (completeness of outcome data) was low
for nine studies (Andersson 2009; Dicko 2011; Djibuti 2009;
Morris 2004; Owais 2011; Pandey 2007; Robertson 2013; Usman
2009; Usman 2011), unclear for two studies (Barham 2005;
Brugha 1996), and high for three studies (Banerjee 2010; Bolam
1998; Maluccio 2004).
Other potential sources of bias
The risk of contaminationwas low for four studies (Banerjee 2010;
Bolam 1998; Owais 2011; Usman 2011), unclear for five studies
(Andersson 2009; Brugha 1996; Djibuti 2009; Pandey 2007;
Usman 2009), and high for five studies (Barham 2005; Dicko
2011; Maluccio 2004; Morris 2004; Robertson 2013).
Effects of interventions
See: Summary of findings for the main comparison
Community-based health education for improving childhood
immunisation coverage; Summary of findings 2 Facility-based
health education plus redesigned reminder card for improving
childhood immunisation coverage; Summary of findings 3
Monetary incentives for improving childhood immunisation
coverage; Summary of findings 4 Home visits for improving
childhood immunisation coverage; Summary of findings 5
Immunisation outreachwith andwithout incentives for improving
childhood immunisation coverage; Summary of findings 6
Integration of immunisation with other health services for
improving childhood immunisation coverage in low- and middle-
income countries
Primary outcomes
Proportion of children who received DTP3 by one year of
age
Recipient-oriented interventions versus standard care
These interventions included health education, use of a combi-
nation of redesigned cards and health education, and a monetary
incentive.
Health education
Included studies considered both community- and facility-based
health education.
Andersson 2009 compared community-based health education
with standard care; Owais 2011 compared community-based
health education with general health promotion given verbally;
and Pandey 2007 compared community-based health education
with no intervention.
Community-based health education probably improved coverage
of DTP3 (RR 1.68, 95%CI 1.09 to 2.59; I2 = 68%; Analysis 1.2).
Overall, there was high heterogeneity between the studies, proba-
bly due to the differing study methods. Certainty of evidence for
community-based health education interventions was moderate
(Summary of findings for themain comparison). Pandey 2007 did
not report DTP3 coverage and was, therefore, not included in this
pooled analysis.
Three studies assessed facility-based health education, and found
substantial heterogeneity of effects (heterogeneity P value <
0.0001; I2 = 91%: Analysis 1.2) (Bolam 1998; Usman 2009;
Usman 2011). As we were unable to explain the heterogeneity,
we did not report the pooled result. The findings from the three
studies showed that the impacts of facility-based education on im-
proving DTP3 uptake range from little to no effect (Bolam 1998:
RR 1.01, 95% CI 0.95 to 1.08) to potentially important benefits
(Usman 2009: RR 1.18, 95% CI 1.05 to 1.33; and Usman 2011:
RR 1.50, 95% CI 1.27 to 1.77).
Health education plus ’reminder-type’ immunisation card
We found low-certainty evidence that combining facility-based
health education with a redesigned ’reminder-type’ immunisation
cardmay improveDTP3 coverage (RR1.50, 95%CI 1.21 to 1.87;
I2 = 77%; Analysis 2.1; Summary of findings 2) (Usman 2009;
Usman 2011).
Provider-oriented interventions versus usual care
One study assessed the impact on immunisation coverage of train-
ing immunisation managers to provide supportive supervision for
health providers (Djibuti 2009). This study provided low-certainty
evidence that the intervention had little or no effect on coverage
for DTP3. The difference in coverage between the intervention
and control groups was 4.3% (P value = 0.285).
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Integration of immunisation with other healthcare services
versus standard care
The Dicko 2011 study provided low-certainty evidence that in-
tegrating immunisation services with intermittent prophylactic
treatment of malaria in infants may improve DTP3 coverage (RR
1.92, 95% CI 1.42 to 2.59; Analysis 6.2; Summary of findings 6).
Proportion of children who received all recommended
vaccines by two years of age
Monetary incentives or disincentives versus no intervention
One study in Nicaragua provided low-certainty evidence that
monetary incentives may have little or no effect on coverage of all
vaccines among children aged 12 to 23 months (RR 1.03, 95%CI
0.83 to 1.28; Analysis 3.2) (Maluccio 2004).One additional study
from Zimbabwe provided low-certainty evidence on the effects of
monetary incentives (Robertson 2013).
Pooled data from these two studies indicated that, overall, there
was low-certainty evidence that monetary incentives may have
little or no effect in improving vaccination coverage, although the
CI included an important benefit (RR 1.05, 95%CI 0.90 to 1.23;
Analysis 3.2; Summary of findings 3) (Maluccio 2004; Robertson
2013).
Immunisation outreach sessions versus no intervention
TheBanerjee 2010 study provided low-certainty evidence that reg-
ular once-monthly reliable immunisation outreach may increase
the coverage for full immunisation (RR 3.09, 95% CI 1.69 to
5.67; Analysis 5.1; Summary of findings 5).
Multi-faceted interventions
Integration of immunisation to other healthcare services
versus standard care
There was low-certainty evidence that integrating immunisation
services with intermittent prophylactic treatment of malaria in
infants may improve DTP3 coverage (RR 1.92, 95% CI 1.42 to
2.59; Analysis 6.2; Summary of findings 6) (Dicko 2011).
Health system plus recipient-oriented interventions versus no
intervention
The Banerjee 2010 study provided low-certainty evidence that
a multi-faceted intervention consisting of a health system (mo-
bile immunisation camp) and recipient-oriented (non-monetary
incentive) intervention may improve coverage for full vaccina-
tion (RR 6.66, 95% CI 3.93 to 11.28; Analysis 5.1; Summary of
findings 5).
Secondary outcomes
Proportion of children who received the vaccine under study
Recipient-oriented interventions versus usual care
Health education
Evidence-based discussions probably improve coverage of measles
vaccine (RR 1.63, 95% CI 1.03 to 2.58; Analysis 1.1) (Andersson
2009). We also found low-certainty evidence that information
campaigns (presentation of audiotape messages, and distribution
of posters and leaflets in the community)may increase the coverage
of at least one dose of a vaccine (RR 1.43, 95% CI 0.72 to 2.86;
Analysis 1.3) (Pandey 2007).
Monetary incentives or disincentives versus no intervention
One study conducted in Mexico provided low-certainty evidence
that monetary incentives may have little or no effect on measles
vaccination coverage (RR 1.00, 95% CI 0.69 to 1.45; Analysis
3.1) (Barham 2005), and coverage of BCG vaccination according
to schedule (RR0.98, 95%CI 0.47 to 2.05; Analysis 3.3) (Barham
2005). However, the CI for BCG uptake included an important
benefit. Morris 2004 reported data on the impact of withdrawing
monetary vouchers (a household-level monetary incentive) on the
coverage of MMR and DTP1 vaccines. The study provided low-
certainty evidence that withdrawing monetary vouchers may have
little or no effect on coverage of MMR (RR 0.95, 95% CI 0.83
to 1.07; Analysis 3.4) and DTP1 (RR 1.09, 95% CI 0.94 to 1.28;
Analysis 3.5).
Provider-oriented interventions versus usual care
Djibuti 2009 provided low-certainty evidence that training im-
munisation managers to provide supportive supervision for health
providers may have little or no effect on coverage for three doses
of oral polio vaccine (OPV3), and three doses of hepatitis B virus
(HBV3). The differences in coverage between the intervention
and control groups were 8.4% (P value = 0.173) for OPV3 and
13.4% (P value = 0.172) for HBV3.
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Health system interventions versus usual care
Home visits versus usual care
Brugha 1996 assessed the effect of home visits on improving cov-
erage for OPV3 and measles. This study provided low-certainty
evidence that home visits may improve OPV3 (RR 1.22, 95% CI
1.07 to 1.39; Analysis 4.1; Summary of findings 4) and measles
vaccine coverage (RR 1.26, 95% CI 1.08 to 1.46; Analysis 4.2).
Multi-faceted interventions
Integration of immunisation to other healthcare services
versus standard care
There was low-certainty evidence that integrating immunisation
services with intermittent prophylactic treatment of malaria in
infants may improve measles vaccine coverage (RR 1.13, 95% CI
1.06 to 1.20; Analysis 6.3), butmay have little or no effect onBCG
coverage (RR 1.03, 95% CI 0.89 to 1.19; Analysis 6.1) (Dicko
2011).
Health system plus provider-oriented interventions versus
standard care
One arm of the study byMorris 2004 aimed to strengthen periph-
eral health services through training QA teams (provider package)
and the provision of equipment, drugs, and materials (health sys-
tem package) and also provided nutritional promotion. This arm
of the intervention was not delivered as per protocol. There was
low-certainty evidence that this intervention may lead to little or
no difference in MMR coverage (RR 1.06, 95% CI 0.91 to 1.23;
Analysis 3.4) and DTP1 coverage (RR 1.00, 95% CI 0.83 to 1.21;
Analysis 3.5).
Health system plus provider-oriented plus participant-
oriented interventions versus standard care
Another arm of Morris 2004 evaluated a combination of mone-
tary incentives (recipient-oriented); QA (provider-oriented); and
provision of equipment, drugs, and materials (health system ori-
ented interventions). The study provided low-certainty evidence
that this intervention may lead to little or no difference in MMR
coverage (RR 1.11, 95% CI 0.99 to 1.24; Analysis 3.4) and DPT1
coverage (RR 1.15, 95% CI 0.97 to 1.37; Analysis 3.5), though
the CIs included important benefits.
Number of children under five years of age fully immunised
with all scheduled vaccines
Monetary incentives
Robertson 2013 and Maluccio 2004 provide low-certainty evi-
dence that monetary incentives may have little or no effect on
coverage of all vaccines among children aged under five years (RR
1.05, 95% CI 0.90 to 1.23; Analysis 3.2; Summary of findings 3).
Occurrence of vaccine preventable diseases
None of the included studies provided data on the occurrence of
the targeted diseases.
Costs of the intervention
Only one of the included studies estimated the costs of the inter-
vention (Andersson 2009). This evaluation indicated that com-
munity-based health education cost USD9.00 per child.
Attitudes of carers and clients towards immunisation
None of the included studies provided data on the attitudes of
caregivers and clients towards immunisation.
Adverse events following immunisation
None of the included studies reported data on AEFI.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Population: children aged 6 weeks
Setting: Pakistan
Intervention: f acility-based health educat ion + redesigned reminder vaccinat ion card
Comparison: standard care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Health education plus re-
designed card
DTP3
(Follow-up: 90 days)
470 per 1000 705 per 1000
(569 to 879)
RR 1.50
(1.21 to 1.87)
1502
(2 studies)3
⊕⊕©©
low1,2
*The effect in the ’health education + redesigned card’ group (and its 95% CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the
intervent ion (and its 95%CI).
CI: conf idence interval;DTP3: 3 doses of diphtheria-tetanus-pertussis containing vaccines; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
’Substant ially dif f erent ’ implies a large enough dif ference that it m ight af fect a decision
1 We rated down by 1 level because of unexplained heterogeneity of ef fects across studies; P value = 0.04; I2 = 77%.
2 We rated down by 1 level because we judged the 2 included studies at unclear risk of select ion bias and at high risk of
performance and detect ion bias.
3 Usman 2009; Usman 2011.
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Population: children aged < 5 years
Setting: Nicaragua (1 study) and Zimbabwe (1 study)
Intervention: monetary incent ives in the form of household cash transfers
Comparison: standard care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Monetary incentive
Fully immunised children
(Follow-up: 13 months to 5
years)
701 per 1000 736 per 1000
(631 to 862)
RR 1.05
(0.90 to 1.23)
1000
(2 studies)2
⊕⊕©©
low1
*The effect in the ’monetary incentive’ group (and its 95% CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; DTP3: 3 doses of diphtheria-tetanus-pertussis containing vaccines; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
’Substant ially dif f erent ’ implies a large enough dif ference that it m ight af fect a decision
1 We rated down by 2 levels because we judged the 2 included studies at high risk of bias.
2 Maluccio 2004; Robertson 2013.
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Population: children aged 12-18 months
Setting: Ghana
Intervention: home visits
Comparison: standard care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95%CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Home visits
OPV3
(Follow-up: 6 months)
73 per 100 89 per 100
(76 to 100)
RR 1.22
(1.07 to 1.39)
419
(1 study)2
⊕⊕©©
low1
*The effect in the ’home visits’ group (and its 95% CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OPV3: 3 doses of oral polio vaccine; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
1 We rated down by 2 levels because the 1 included study was judged to be at high risk of bias.
2 Brugha 1996.
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Population: children aged 0-6 months
Setting: India
Intervention: regular immunisat ion outreach with or without household incent ives
Comparison: standard care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Immunisation outreach
Fully immunised - regular
immunisat ion outreach only
(Follow-up: 18 months)
58 per 1000 180 per 1000
(98 to 330)
RR 3.09
(1.69 to 5.67)
1239
(1 study)2
⊕⊕©©
low1
Fully immunised - regular
immunisat ion outreach +
non-monetary incent ive
(Follow-up: 18 months)
58 per 1000 387 per 1000
(228 to 656)
RR 6.66
(3.93 to 11.28)
1242
(1 study)2
⊕⊕©©
low1
*The effect in the ’immunisation outreach’ group (and its 95% CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the intervent ion (and
its 95% CI).
CI: conf idence interval; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
’Substant ially dif f erent ’ implies a large enough dif ference that it m ight af fect a decision
1 We rated down by 2 levels because we judged the 1 included study at high risk of bias.
2 Banerjee 2010.
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Population: children aged 0-23 months
Setting: Mali
Intervention: integrat ion of immunisat ion services with interm it tent prevent ive treatment of malaria
Comparison: standard care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evidence
(GRADE)
Standard care Integration
DTP3
(Follow-up: 12 months)
602 per 1000 1000 per 1000
(854 to 1000)
RR 1.92
(1.42 to 2.59)
1481
(1 study)2
⊕⊕©©
low1
*The effect in the ’integration’ group (and its 95%CI) was based on the assumed risk in the ’standard care’ group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; DTP3: 3 doses of diphtheria-tetanus-pertussis containing vaccines; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: This research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate certainty: This research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is moderate
Low certainty: This research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent is high
Very low certainty: This research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is very high
’Substant ially dif f erent ’ implies a large enough dif ference that it m ight af fect a decision
1 We rated down by 2 levels because we judged the 1 included study at high risk of bias.
2 Dicko 2011.
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D I S C U S S I O N
Summary of main results
Ten cluster RCTs and four individually randomised controlled tri-
als met our inclusion criteria. These were conducted in Georgia,
Ghana, Honduras, India, Mali, Mexico, Nepal, Nicaragua, Pak-
istan, and Zimbabwe. The interventions evaluated in the studies
included community-based health education, facility-based health
education, home visits, household monetary incentives, and inte-
gration of immunisation services to intermittent preventive treat-
ment of malaria. These were implemented either as single inter-
ventions or as multi-faceted interventions.
We found moderate-certainty evidence that giving information
and discussing vaccination with parents and other community
members at village meetings or at home probably improve immu-
nisation coverage. We also found low-certainty evidence that giv-
ing information to parents about the importance of vaccinations
during visits to health clinics combined with specially designed
’reminder-type’ immunisation cards may improve immunisation
coverage. Therewas low-certainty evidence that regular immunisa-
tion outreach, home visits, and integration of immunisation with
other primary healthcare services (such as intermittent preventive
treatment of malaria) may improve immunisation coverage. How-
ever, there was currently low-certainty evidence that household
monetary incentives (in the form of conditional or unconditional
cash transfers) may have little or no effect on immunisation cov-
erage.
Overall completeness and applicability of
evidence
In the context of the GVAP, there is an urgent need for effective in-
terventions that would ensure equitable uptake of existing vaccines
by people in all communities around the world (WHO 2012a).
However, immunisation coverage remains uneven between and
within the world’s regions and countries. For example, in 2014,
DTP3 coverage was 96% in Europe and the Western Pacific and
only 77% in sub-Saharan Africa (WHO 2015). The GVAP cover-
age target was to achieveDTP3 coverage of 90% in all countries by
2015; but only 129 (66%) countries have achieved this coverage
target. The 10 countries with the largest numbers of unimmunised
children are all low-income or lower- to middle-income countries
(SAGE 2015).
Barriers to improving immunisation coverage could be broadly
categorised into factors that affect the demand for vaccines, barri-
ers to the supply of vaccines, or both (Lewin 2011). Around 2014,
the concept of vaccine hesitancy emerged as a factor hindering the
demand of vaccines (Larson 2014). The Strategic Advisory Group
of Experts on immunisation identified factors that influence vac-
cine hesitancy. These were grouped into three major areas, namely
contextual influences, vaccine and vaccination specific issues, and
individual and social group influences. The influences of these fac-
tors are said to be complex and context-specific, varying in time,
place, and vaccine (Larson 2014). It is unclear if the interventions
tested in the included studies were derived from identified barriers
in the settings, though specific concepts were tested. In general,
though, interventions to improve coverage should focus on iden-
tified barriers within settings.
The included studies evaluated interventions that varied enor-
mously in content and in the intensity of delivery, raising ques-
tions regarding the likely impact of interventions in different set-
tings and regarding how best to implement the interventions. For
instance, how effective will a three-minute health education inter-
vention (Usman 2009; Usman 2011; low-certainty evidence) be
in a typical clinical setting in improving completion of the immu-
nisation schedule? Will the same effect be obtained for more than
one vaccine?How feasible is evidence-based discussion (Andersson
2009; moderate-certainty evidence) in a community with low lit-
eracy? How feasible is a monetary incentive intervention (Morris
2004; low-certainty evidence) in a resource-poor setting without
donor support? The limited number of studies makes it difficult
to explore these issues and restricts the wider applicability of the
evidence.
Home visits to promote childhood vaccination uptake or to de-
liver vaccination are common in many settings. The applicability
of the home visit intervention as implemented in Brugha 1996
may be affected by several factors. First, the use of first-degree
university students as lay/community health workers to deliver
this type of intervention may not be feasible in many resource-
poor settings. Two reviews reported moderate-certainty evidence
on the effectiveness of lay health workers in promoting the uptake
of childhood immunisation services (Glenton 2011; Lewin 2010).
In these reviews, the level of education of the lay health workers
varied from primary school graduates to high school graduates,
with some studies not reporting this information. Furthermore,
the settings of the studies were middle- and high-income coun-
tries. Second, referring caregivers of children who need immuni-
sation to a health facility requires that there be a facility within
reasonable distance of the community. This type of intervention
may not be useful in settings in which households do not have easy
access to health facilities. Finally, administering injectable vaccines
at home has implications for vaccine quality and injection safety;
given the need to maintain the cold chain from manufacture to
administration of vaccines as well as the need to dispose of in-
jection material safely (preferably by incineration). This approach
may not be cost effective or sustainable in a resource-constrained
economy. The high diversity of the interventions and the contex-
tual differences, therefore, make it difficult to draw conclusion on
their effectiveness in improving vaccination coverage.
There is paucity of data on the sustainability of the interventions
presented in this review, as none of the included studies reported
long-term follow-up data. All had two data points that were at
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baseline and post-intervention, making it impossible to ascertain
the long-term effects of the interventions. However, two studies
aimed to build the capacity of the providers (Djibuti 2009;Morris
2004), and to upgrade the physical structure (Morris 2004). These
strategies can contribute to sustainability if other supporting re-
sources are available. A sustainability framework for projects aimed
at strengthening immunisation systems in LMICs should include
maintenance or continuance of health benefits from projects, in-
stitutionalisation of projects within the system, and capacity de-
velopment (Gruen 2008; Shediac-Rizkallah 1998). It has been ob-
served that for a programme to be sustained, early and active plan-
ning is required (Shediac-Rizkallah 1998). Sustainability of qual-
ity improvement interventions has been particularly challenging
in LMICs, especially when a programme is supported by exter-
nal funds (Gruen 2008). Withdrawal of external funds may not
only impact negatively on the gains of the programme but may
jeopardise support for future programmes (Gruen 2008). This is
particularly so when the intervention is cost intensive.
Information on the resource implications of interventions may be
helpful in determining their long-term sustainability and cost ef-
fectiveness. Only one study provided data on the cost of the inter-
vention (Andersson 2009). This study reported that community-
based health education in Pakistan costs USD9.00 per child. The
cost of interventions would depend on the context of the interven-
tion, as the cost to vaccinate a child fully has been reported to vary
between USD1 and USD40 in LMICs (Shea 2009). Therefore,
the cost of interventions should be reviewed within the context
and settings of the studies. As part of their systematic review on the
effects of lay or community health workers in primary health care
(Glenton 2011; Lewin 2010), Glenton and colleagues reviewed
the costs and cost-effectiveness of vaccination programme inter-
ventions involving lay health workers (Corluka 2009). The au-
thors found that studies did not adequately address affordability
and sustainability and were also highly heterogeneous in terms of
settings and outcomes, limiting their comparability. In addition,
they found insufficient data to allow any conclusions to be drawn
regarding the cost-effectiveness of lay health worker interventions
to promote vaccination uptake. Studies focused largely on health
outcomes and did illustrate to some extent how the institutional
characteristics of communities, such as governance and sources of
financial support, influence sustainability (Corluka 2009). Con-
sidering that the interventions assessed in this review were set up as
parallel programmes, rather than being integrated into routine ser-
vices, it is unclear how effective theywill be if integrated with other
services within the system, with the typical levels of human and
other resources available. This calls for cost-effectiveness evalua-
tions of these interventions, particularly as integrated rather than
stand-alone programmes (Dicko 2011; Okwo-Bele 2012). Such
evaluations also have limitations as it can be difficult to translate
these findings from one setting to another. Therefore, there is need
for study authors to provide the details of the required resources
to implement the intervention.
Many immunisation programmes in LMICs are delivered as mass
immunisation on set ’immunisation days’, following mass im-
munisation campaigns (Balraj 1986; Bandyopadhyay 1996; Berry
1991; Cutts 1990;Gomber 1996; Kumar 1990; Lin 1971; Linkins
1995; Shaikh 2003). None of the reports of this commonly used
strategy met the criteria for inclusion in our review or for the
Saeterdal 2014 Cochrane review on interventions aimed at com-
munities to inform and /or educate on early childhood vaccina-
tion. Shea 2009 has noted that it may be difficult to randomise
mass media interventions. However, ITS designs could be used to
assess the effects of these mass immunisation campaigns on im-
munisation coverage (Nglazi 2014).
Quality of the evidence
This review included 14 studies, three had unclear risk of bias
(Andersson 2009; Owais 2011; Pandey 2007), while all the oth-
ers had high risk of bias. The main study limitations were non-
concealment of allocation, no blinding, lack of protection against
contamination, and extraneous sources of bias. The cluster RCTs
were adjusted for cluster effects. Overall, the certainty of the evi-
dence for most interventions was low. This implies that the cur-
rently available research provides some indication of the likely ef-
fect of the interventions. However, the likelihood is high that the
true effect of the interventions will be substantially different.
Potential biases in the review process
We minimised bias in the process of conducting and reporting
the current review by adhering to standard Cochrane guidelines
(Higgins 2011). However, access to studies from LMICs is lim-
ited to those studies published in indexed journals. There may
be a need to identify non-indexed local journals and the grey lit-
erature in low-income countries, and to conduct handsearching
of these sources. In addition, as noted by Machingaidze and col-
leagues, due to the broad nature of childhood immunisation (en-
compassingmany different components) identifying a search strat-
egy that includes all aspects of childhood immunisations is chal-
lenging (Machingaidze 2014). However, in one 2014 Cochrane
review on community-aimed interventions to inform and educate
about childhood vaccination, the authors did not identify addi-
tional studies to those included in this review (Saeterdal 2014).
Agreements and disagreements with other
studies or reviews
Several previous systematic reviews assessed the effectiveness of
interventions for improving childhood immunisation coverage (
Batt 2004; Bordley 2000; Giles 2014; Glenton 2011; Jacobson
Vann 2005; Johri 2015b; Kaufman 2013; Kendrick 2000; Pegurri
2005; Ryman 2008), although very few of them included studies
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from LMICs (Batt 2004; Glenton 2011; Pegurri 2005; Ryman
2008), and many were already out-of-date as the dates of the most
recent searches for the reviews were pre-2005 (Batt 2004; Bordley
2000; Jacobson Vann 2005; Kendrick 2000; Pegurri 2005).
Measures of effect for participant reminders in this review tend
to agree with a now out-of-date systematic review of interven-
tions aimed at reminding people of their immunisation sched-
ules (Jacobson Vann 2005). Home visits, participant reminders
through a redesigned immunisation card, and health education
improved the uptake of immunisation in this review. Similarly,
telephone calls, sending of letters and postcards, and speaking to
clients in person improved the coverage of childhood vaccines in
the participant-reminder review (Jacobson Vann 2005).
We found low-certainty evidence that monetary incentives (in the
form of vouchers, conditional, and unconditional cash transfers)
may have little or no effect on uptake of vaccines. This differs from
the findings of several related systematic reviews: one systematic
review on the effect of conditional cash transfers on health out-
comes and the use of health services reported an improvement in
the use of health services but, similar to this review, reportedmixed
results for uptake of immunisation in children (Lagarde 2009a).
Two older (and now out of date) reviews also reported on the ef-
fects of this intervention (Giuffrida 1997; Kane 2004). One more
recent review on the topic included 16 studies from high-income
countries on smoking cessation (10 studies), attendance for vacci-
nation or screening (five studies), and physical activity (one study)
(Giles 2014). It reported an increase in vaccination and screening
attendance with monetary incentives. However, subgroup analysis
showed that cash plus other motivational components was more
effective than cash or vouchers alone. The differences between
our review findings and those of this review may reflect differ-
ences across settings (high-income compared to low- and middle-
income countries) or limitations of the studies included in our
review. In addition, the Morris 2004 study findings were of low
certainty because of high risk of bias.
Ryman and colleagues conducted a comprehensive search in 2005
to identify peer-reviewed and grey literature on strategies for im-
proving childhood immunisation coverage in LMICs (Ryman
2008). They identified 25 studies that included an appropriate
control group, and grouped the papers into four strategic ap-
proaches: bringing immunisation closer to communities (11 stud-
ies), using information dissemination to increase demand for vac-
cination (three studies), changing practices in fixed sites (four
studies), and using innovative management practices (seven stud-
ies). The studies included RCTs, nRCTs, CBAs, and observational
studies, and reported improvements in immunisation coverage of
varying degrees. Unlike Ryman and colleagues, we excluded ob-
servational studies. We included CBAs if they had more than two
units in both the intervention and control groups, in accordance
with EPOC guidance (EPOC 2015a). Though the Ryman review
identified studies that reported improvements in immunisation
coverage, they noted that the indicators of success varied widely
making it impossible for the data to be merged in a meta-analysis
(Ryman 2008).We also found that studies reported immunisation
outcomes in a variety of ways, for example, proportion of chil-
dren aged 12 to 23 months who had received measles, proportion
of children aged 12 to 23 month who had received full course
of DTP (Andersson 2009); probability of receiving at least one
immunisation (excluding OPV), the presence of the BCG scar,
the number of immunisations received, the probability of being
fully immunised (Banerjee 2010); immunisation full coverage of
children aged 12 to 23 months with three doses of DTP, BCG,
and measles vaccines (Barham 2005); DTP3 coverage at the end
of day 90 post-enrolment (Usman 2011), etc. However, our fore-
knowledge of childhood immunisation programmes guided our
decisions regarding which outcomes were synonymous (and thus
can be combined in a meta-analysis) and which are not.
In a related systematic review, Glenton and colleagues assessed the
effects of lay or community health worker interventions on child-
hood immunisation coverage (Glenton 2011). They conducted
the last search in 2009, and identified 12 studies; including 10
RCTs. Five of the studies were carried out in LMICs. In 10 stud-
ies, community health workers promoted childhood immunisa-
tion and in the remaining two studies, community health workers
vaccinated children themselves. Most of the studies showed that
the use of lay or community health workers to promote immu-
nisation uptake probably increased the number of children who
were fully immunised. Our findings on the effect of community-
based health education and home visits were consistent with these
findings.
Johri and colleagues reported a systematic review of “strategies to
increase demand for vaccination are effective in increasing child
vaccine coverage in low- and middle-income countries”. The au-
thors concluded that, “demand-side interventions are effective in
improving the uptake of childhood vaccines delivered through
routine immunization services in low- and middle-income coun-
tries” (Johri 2015b).
Finally, our review is related to two other Cochrane reviews
(Kaufman 2013; Saeterdal 2014); conducted under the auspices of
the ’Communicate to Vaccinate’ project (Lewin 2011). Kaufman
2013 assessed the effects of face-to-face interventions for inform-
ing or educating parents about early childhood vaccination on im-
munisation uptake and parental knowledge and Saeterdal 2014
reviewed interventions aimed at communities to inform or edu-
cate (or both) about early childhood vaccination. The two reviews
included studies from any setting while this review focused on low
LMICs. We included three of the studies (Bolam 1998; Usman
2009; Usman 2011) included in the Kaufman 2013 review in our
review and two studies (Andersson 2009; Pandey 2007) from our
review were included in the Saeterdal 2014 review. While the find-
ings of this review were similar to the findings of the Saeterdal
2014 review (i.e. that these interventions probably increase im-
munisation coverage), they differed from the findings of Kaufman
2013 that reported little or no improvement in immunisation cov-
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erage. This may be because Kaufman included studies from high-
, middle-, and low-income countries.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Barriers to immunisation uptake are context related. For any in-
tervention to be adopted in a setting it must be designed to meet
the peculiar needs of the setting and in the magnitude that best
addresses the needs. Studies included in this review tested gen-
eral concepts that were not linked with identified needs or barri-
ers in the study settings. In addition, the certainty of evidence of
the included studies was mostly low. This infers that even within
the same setting, the likelihood of the observed effect being sub-
stantially different is high. In one systematic review to identify
determinants of vaccine hesitancy in different settings, including
their context-specific causes, expression, and impact, Larson 2014
reported that these factors could not be considered in isolation
as there were multiple influences at play. Further, individual fac-
tors may have conflicting effects even in the same setting. For in-
stance, low-income status was both a promoter and a barrier to
vaccination in Nigeria. As a barrier it was linked with access and
low education. Adopting interventions without considering other
confounding factors may produce little or no effect, as this review
demonstrated.
This review showed that evidence-based discussion that aims at
knowledge translation to community members may be more ef-
fective than conventional health education strategies. However, it
has been observed that interventions such as community meet-
ings may be cost intensive and so should be adopted with caution
(Saeterdal 2014). Health system interventions such as home visits
and regular immunisation outreach sessions are likely to be useful
for difficult-to-reach communities though there were no data to
assess the cost of their implementation. Overall, the magnitude of
effect of these interventions is small and sustainability over long
periods is uncertain. Participant reminder interventions have con-
sistently shown improvement in vaccination in this review from
studies in low-and middle-income countries and in another re-
view from high-income countries (Jacobson Vann 2005). There-
fore, it may be possible to adapt this intervention to suit different
settings. There is low-certainty evidence that monetary incentives
have little or no effect on immunisation uptake. Another review
suggested that such incentives may fail to improve coverage when
other barriers to immunisation exist (Lagarde 2009a). The afford-
ability and sustainability of incentives is uncertain in low- and
middle-income countries, particularly when supported by external
funds. Implementation, particularly in low- and middle-income
countries, may, therefore, need to be accompanied by rigorous
evaluation.
Implications for research
Despite the vast investment of resources in improving vaccination
coverage in low- and middle-income countries few studies, and
only low- to moderate-certainty findings, are available to inform
policy and decision making on vaccination in these settings. The
certainty of the existing evidence implies that the likelihood is
high that the true effect of the interventions will be substantially
different. Therefore, this review suggests thatmore rigorous studies
are required to evaluate:
1. participant reminder and recall interventions that are
adaptable to low- and middle-income countries as this approach
has been shown to be effective in high-income countries;
2. community-based health education strategies, including
mass campaigns, as these interventions may be more effective
than facility-based health education;
3. provider-oriented and multi-faceted interventions (e.g.
reaching every district strategy) for improving childhood
immunisation coverage in low- and middle-income countries;
4. regulation to make vaccination a requirement for school
entry, and, therefore, increase vaccination coverage;
5. incentives for vaccination providers;
6. plans of action for immunisation coverage and disease
reduction.
These studies may also need to include:
1. measures of sustainability such as integration into routine
immunisation services, long-term impact of the interventions,
and incidence of targeted diseases;
2. Cost-effectiveness of various interventions and resource use
and unit costs for vaccination for different strategies.
These studies should be based on factors influencing vaccination
uptakewithin specified context, identified fromqualitative studies,
to aid translatability to similar contextual settings. Larson 2014 has
identified the paucity of qualitative data as a setback to identifying
how factors associated with vaccine hesitancy interact with one
another.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andersson 2009
Methods Cluster RCT in Pakistan
Participants Setting: Lasbela, 1 of the poorest districts in Balochistan Province in Pakistan
Aim: authors hypothesised that if the community accessed information on the cost-
benefits of immunisation, the uptake of vaccines would improve without requiring im-
provement in service delivery
Participants: 180 community groups with each group having 8-10 participants, both
male and female. Outcome measured in children aged 12-23 months; 911 children at
pre-intervention and 956 at post-intervention
Interventions Intervention: evidence-based discussion on immunisation in 18 clusters: trusted members
of the committee were selected for a 3-phased discussion. 9 field teams (facilitators) had
discussion with 180 community groups of 8-10 members each in 94 villages for the
intervention group. 3 phases of discussion were held with the community groups. First
phase the community groups discussed the situation of child immunisation in the union
council, the smallest unit of the local government system. Facilitators discussed the risk
of non-vaccination for measles with the community groups. Second phase, discussed
cost-benefits of vaccination and treatment of measles. Third stage featured discussion on
challenges of immunisation and identification of barriers and plans of action to increase
access for immunisation services and means of spreading the discussion on vaccination
Control: usual care in 14 clusters
Outcomes Proportion of 12-23 month olds who had received measles vaccination
Proportion of 12-23 month olds who had received full course of DPT
Duration of intervention August 2006 to May 2007 (9 months)
Notes Follow-up after 1 year (baseline conducted in spring 2005; follow-up spring 2007)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator allocated baseline communities
to 18 intervention enumeration areas and 14 control enu-
meration areas
Allocation concealment (selection bias) Low risk Sequence concealed and intervention assigned centrally
Blinding (performance bias and detection
bias)
All outcomes
Low risk Interviewers did not know which clusters had received the
intervention, only the field co-ordinator knew
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Andersson 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Not applicable. Samples taken pre- and post-intervention
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias High risk “Although the facilitators discussed with participants their
plans for disseminating the discussions within their commu-
nities, the intervention did not make special provision for
the participants to ’take back’ the discussion to others in the
community, relying rather on endogenous networks for the
information spill over.” In addition, use of mothers’ recall for
immunisation uptake may under estimate vaccine coverage
Unit of study was enumeration area, analysis done at partic-
ipant level; no adjustment for cluster effect
Baseline outcome measurements similar? Low risk Yes
Baseline characteristics similar? Low risk Baseline characteristics similar except, “mothers willing to
travel to vaccinate”, which was higher in the intervention
than the control group
Adequate protection against contamina-
tion?
Unclear risk Measure to prevent contamination not stated
Banerjee 2010
Methods Cluster RCT in India
Participants Setting: disadvantaged rural community in Udiapur, India with 2% immunisation cov-
erage
Aim: to test the effect of reliable supply of free immunisation services and incentive to
improve vaccine demand in a resource-poor setting
Participants: 1640 children aged 0-6 months at baseline or 1-3 years at the endpoint
survey
Interventions Intervention A: once monthly reliable immunisation camp without incentive (379 chil-
dren from 30 villages at endpoint). Intervention focused on establishing regular avail-
ability of immunisation services. Consisted of a mobile immunisation team, including a
nurse and assistant, who conducted monthly immunisation camps in the villages. Camp
held on a fixed date every month at a fixed time (11 am to 2 pm). Presence of nurse and
assistant verified by requirement of timed and dated pictures of them in the villages and
by regular monitoring
Intervention B: once monthly reliable immunisation camp with small incentives con-
sisting of raw lentils and metal plates for completion of schedule (382 children from 30
villages at endpoint). Intervention used the same infrastructure as intervention A but in
addition offered parents 1 kg of raw lentils per immunisation administered and a set of
“thalis” (metal plates used for meals) on completion of a child’s full immunisation. Value
of the lentils about USD1, equivalent to three-quarters of 1 day’s wage, and the value of
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Banerjee 2010 (Continued)
the “thalis” about USD2
Control: no intervention (860 children in 74 villages at endpoint)
Outcomes Probability of receiving at least 1 immunisation (excluding OPV, which almost all chil-
dren received)
Presence of the BCG scar
Number of immunisations received
Probability of being fully immunised. A fully immunised child received all the vaccines
in the EPI schedule (1 dose of BCG, 3 doses of DTP, 3 doses of OPV, and 1 dose of
measles vaccine) by the age of 1 year
Duration of intervention 18 months
Notes Study conducted in rural state of Rajasthan, India
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Using the random number generator in the statistical package
Stata (version 9), and after stratification by geographical block
(the administrative unit above the village), one author (ED)
randomly selected 30 of the 134 study villages to receive inter-
vention A and 30 to receive intervention B. The 74 remaining
villages were control villages and received no additional inter-
vention”
Allocation concealment (selection bias) Low risk “Within each village, a household censuswas conducted, and 30
households containing children aged 0-5 years were randomly
selected with a random number generator to be part of the
sample. The same households were surveyed again at the end
point. The criterion for inclusion of a child in this study was
to belong to a sampled household and to be aged 1-3 at the
end point of the study (main sample) or to have been aged 0-6
months at baseline (baseline cohort)”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The allocation of villages to treatment or control was not blind.
.. Surveys were undertaken in randomly selected households at
baseline and about 18 months after the interventions started
(end point)... Interviewers did not know which villages be-
longed to which intervention (or control) group”
Incomplete outcome data (attrition bias)
All outcomes
High risk Households lost between baseline and endpoint: 16% (71/453)
in interventionA group, 17%(72/481) in interventionB group,
and 17% (210/1224) in control group; 17% (363/2158) overall
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Low risk None
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Baseline outcome measurements similar? Low risk Yes
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Low risk “Villages from all three treatment groups were sufficiently far
from each other (over 20 km) so we expected no contamination
between the villages”
Barham 2005
Methods Cluster RCT in Mexico
Participants Setting: Nicaragua, Mexico with immunisation rate > 90%
Participants: 506/50,000 eligible villages randomly chosen
Intervention groups: selected from 320 communities
Control group: selected from 186 communities
Value of the transfers: USD25, adding 20-30% to the household income
Interventions Intervention: 2 cash transfers every 2 months; 1 general and 1 depending on school
attendance
1. nutrition component: food supplements for children aged 4-23 months, under-
weight children aged 2-4 years, and pregnant and lactating women in beneficiary
households
2. health component: regular healthcare appointments in health centres for the
whole family
3. education component
Control: Usual care
Outcomes Immunisation full coverage of children aged 12-23 months with 3 doses of DPT, BCG,
and measles vaccines
Duration of intervention 12-35 months
Notes The controls should originally have acted as controls for 2 years, but for political reasons
intervention in control communities occurred in late 1999 so only 18 months of com-
parison was possible and the control communities were, therefore, considered as cross-
over intervention communities after 1 year of observation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not stated
Allocation concealment (selection bias) High risk Not stated
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Blinding (performance bias and detection
bias)
All outcomes
High risk Study was not blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not applicable
Selective reporting (reporting bias) Unclear risk Study protocol not seen
Other bias Unclear risk Not stated
Baseline outcome measurements similar? High risk Baseline level of vaccination rate lower in treatment group
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Unclear risk Protection against contamination not stated.
Bolam 1998
Methods RCT in Nepal
Participants Setting: main maternity hospital in Kathmandu, Nepal
Aim: tested the effectiveness of 1-to-1 health education with perinatal mothers in a
hospital setting in Nepal on infant care and family planning
Participants: 540 post-partum women
Interventions Intervention A: 20 minute, 1-to-1 health education immediately after birth and 3
months later
Intervention B: 20 minute, 1-to-1 health education at birth only
Intervention C: 20 minute, 1-to-1 health education at 3 months only
Intervention D: control (no individual health education)
Outcomes Duration of exclusive breastfeeding
Appropriate immunisation of infant
Knowledge of oral rehydration solution and need to continue breastfeeding in diarrhoea
Knowledge of infant signs suggesting pneumonia
Uptake of postnatal family planning
Duration of intervention 20-minute, individual health education at birth and 3 months later. Outcomes assessed
at 3 and 6 months
Notes First education session conducted in quiet room before discharge from hospital. Second
education session conducted in the mothers’ home 3 months after delivery. Although
the health education given at birth and 3 months covered broadly the same areas, more
emphasis was placed on the importance of exclusive breastfeeding in the first session and
on the need for family planning in the second session. Topics covered were infant feed-
ing, treatment of diarrhoea, recognition of and response to symptoms suggesting acute
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respiratory infection in young infants, importance of immunisation, and importance of
contraception after the puerperium. At the end of each session, health educator repeated
the key messages covered and asked mother if she had any other questions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Restricted randomisation was used in blocks of 20, each block
consisting of a random ordering of the numbers 019. Numbers
04, 59, 1014, and 1519 were assigned to groups A to D respec-
tively”
Allocation concealment (selection bias) Unclear risk “Timing of assignment was when a mother was identified by the
research team either in labour or shortly after delivery. The de-
tails of allocation to groups for consecutively recruited mothers
were in sealed envelopes... The generator of the assignment was
not involved in the execution of the allocation”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The mothers recruited and the health educators were not blind
to the assignment of mothers to different groups. The outcome
assessors were always blind to the assignment at both the 3 and 6
month followup visits. Staff whowere involved indata collection
at the 3 month follow up were not involved in data collection
at 6 months. The data analysts were not blind to the coding of
the groups”
Incomplete outcome data (attrition bias)
All outcomes
High risk Each of the 4 groups (A-D) had 135 women. At 6 months,
percentage of women lost-to-follow-up was 29% in group A,
21% in B, 26% in C, and 24% in D
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Low risk None
Baseline outcome measurements similar? Low risk Not applicable
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Low risk Yes
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Methods Matched and cluster RCT in Ghana
Participants Setting: urban settings in Ghana with regular immunisation services
Aim: addressing low immunisation coverage in spite of developed immunisation infras-
tructure
Participants: children aged 12-18 months. Included 200 mother-and-child pairs in the
intervention group and 219 in the control group
Interventions Intervention: home visits in 30 clusters. During home visits, interviewers (university
students) administered questionnaires to mothers or female caregivers and fathers or
male caregivers of children aged 12-18 months. Immunisations recorded from road-to-
health card or clinic record (if card was missing) in a register. All respondents advised to
bring identified children who had not completed immunisation schedule to the clinic
for immunisation. A referral note was given to each child to bring to the clinic. Children
who failed to complete immunisation were identified from the register and a maximum
of 3 home visits made to each child within 6 months
Control: standard care in 30 clusters
Outcomes Completion of polio1, OPV3, and measles
Completion of schedule
Duration of intervention 6 months
Notes 6 months of follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Contiguous clusters were paired, as far as pos-
sible within enumeration areas, and one of each
pair of clusters was randomly chosen for the sur-
vey...”
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
High risk Neither the provider nor the child was blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Lost to follow-up not accounted for
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in protocol
Other bias High risk Children in registered and unregistered houses
included in intervention group but only children
in registered houses included in control group
Analysis done at cluster level; also took matching
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into account at analysis
Baseline outcome measurements similar? Low risk Baseline immunisation coverage in the 2 groups
were not statistically significant
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Unclear risk Though “contiguous clusters were paired as far
as possible within the enumeration area”, it was
unclear if they were protected from contamina-
tion
Dicko 2011
Methods Cluster RCT in Mali
Participants Setting: Kolokani, a district in Mali hyperendemic for malaria and with immunisation
level < 50%
Participants: children aged 0-23 months
Interventions Intervention: intermittent preventive treatment of malaria in infants (in 11 clusters), i.
e. administration to infants of ½ tablet of sulphadoxine-pyrimethamine along with EPI
vaccines (DTP2, DTP3 and measles/yellow fever vaccine). Communities leaders were
sensitised and health staff were trained. Supports for child health interventionsweremod-
ified to allow the recording of the administration of the sulphadoxine-pyrimethamine
along with EPI vaccines and the health interventions
Control: standard care in 11 clusters
Outcomes Proportion of 9-23 months old children completely immunised with BCG, 3 doses of
DTP, 1 dose of measles, and yellow fever vaccines
Duration of intervention 12 months
Notes Study conducted from December 2006 to December 2007. Sample size for the baseline
survey estimated using the following assumptions. Based on a precision of 6% and alpha
error of 5% and DTP3 coverage of two-thirds (67%), a sample of 472 children was
selected using a cluster effect of 2. This sample size was doubled to take into account
analysis for specific age categories and increased by 10% to take into account missing
information, making a total sample size of 1050 children aged 0-23 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Simple balloting. “The health areas were numbered from 1 to 22
and each number was written on piece of paper that was folded.
The 22 pieces of paper were then mixed and placed in box and
11 of them were randomly drawn to serve as intervention areas
by one of the trainees in presence of the representatives of the
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22 communities’ health centres”
Allocation concealment (selection bias) High risk “The study was an open cluster-randomised trial... The health
areas were numbered from 1 to 22 and each number was written
on piece of paper that was folded. The 22 pieces of paper were
then mixed and placed in box and 11 of them were randomly
drawn to serve as intervention areas by one of the trainees in
presence of the representatives of the 22 communities’ health
centres”
Blinding (performance bias and detection
bias)
All outcomes
High risk Study was open cluster-randomised trial. 2 cross-sectional sur-
veys (using theWHOmethod of evaluation of vaccine coverage)
performed, 1 at baseline and 1 after 1 year of the intervention.
Did not state whether the people conducting the survey were
aware of the treatment allocations or not
Incomplete outcome data (attrition bias)
All outcomes
Low risk Not applicable; 2 independent samples taken pre- and post-
intervention
Selective reporting (reporting bias) Low risk No selective reporting
Other bias Low risk None
Baseline outcome measurements similar? High risk No. Difference was statistically significant
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
High risk Training of staff was carried out in both control and intervention
communities, followed by public randomisation
Djibuti 2009
Methods Cluster RCT in Georgia
Participants Setting: low immunisation coverage despite healthcare reforms. Human resource man-
agement was weak with lack of knowledge and skills in management and supervision
especially at the peripheral levels
Participants: district immunisationmanagers, PHCproviders. Number of health workers
studied was 392 at pre-intervention and 521 at post-intervention. Apart from outcome
measures from PHC workers, data were obtained on children’s immunisation
Interventions Intervention: development of supportive supervision guidelines for district immunisation
managers in 15 clusters: intervention consisted of development of supportive supervision
guidelines and tools for district managers, training in continuous supportive supervision,
monitoring, and evaluation of performance. Each district manager visited subordinated
health facility at least once a month. On-the-job training was provided for immunisation
managers to improve on supervision practices to help providers solve problems encoun-
tered in immunisation
Control: no intervention in 15 control clusters
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Outcomes DTP3, polio 3, and HBV3 coverage
Difference in proportion of coverage from baseline
Duration of intervention 12 months
Notes Follow-up study conducted after 1 year of intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Stratified cluster randomisation was used to select the 30
cluster units out of the nation’s 67 districts and allocate them
into the two study groups (intervention and control), yield-
ing two allocation sequences of 15 clusters each”
Allocation concealment (selection bias) Unclear risk “Given that immunization managers supervise health work-
ers only within their districts, and similarly health workers
provide immunization services to target population residing
in communities within the same district, the risk of contam-
ination of the control group with the intervention is neg-
ligible. Use of smaller units (e.g. village) would have posed
a higher risk of contamination of intervention activities in
control clusters”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk Not applicable; 2 independent samples taken pre- and post-
intervention
Selective reporting (reporting bias) Unclear risk Unclear if all the outcomes stated in the protocol were re-
ported on
Other bias High risk During the course of intervention, the country improved
healthcare financing for low-income people and there was
also improved country level economic growth thus improv-
ing access to health care. “It is possible that improved access
to health care may have contributed to improved immuniza-
tion coverage in Georgia”
Unit of studywas district, but unit of analysis was participant.
No adjustment for clustering effect
Baseline outcome measurements similar? Low risk Yes
Baseline characteristics similar? Low risk Demographic and employment characteristics were similar
among Center of Public Health staff respondents in the in-
tervention and control groups, both at baseline and follow-
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up except mean years of experience, which was more among
the control group
Adequate protection against contamina-
tion?
Unclear risk Protection against contamination unclear
Maluccio 2004
Methods Cluster RCT conducted in Nicaragua (Red de proteccion social)
Participants Setting: part of a social safety net programme targeted at poor households living in rural
areas, but the pilot phase analysed in this study occurred in 2 departments (Madriz and
Matagalpa) in the Northern part of the Central Region. This region is the only one in
the country where poverty worsened during 1998 and 2001
These pilot sites were not representative of the country situation: within the 2 chosen
departments, 6 municipalities were chosen (out of 20) because they had benefited from
a previous programme that developed the capacity of the governing bodies to implement
and monitor social projects: “it is possible that the selected municipalities had atypical
capacities to run RPS” in the chosen municipalities, 78-90% of the population was ex-
tremely poor/poor, compared to 21-45% at national level. 42 eligible areas (the neediest)
were chosen for the pilot programme based on wealth index
Private providers were specifically trained to deliver the specific healthcare services re-
quired by the programme. Incentives were also given to teachers to compensate for the
larger classes they had after the implementation of the programme. 10% of beneficiaries
were penalised at least once during the first 2 years of the programme; 5% were expelled
or left the programme. Some conditions (adequate weight gain) were dropped at the end
of the pilot phase and others were not properly enforced (up-to-date vaccination while
there were delays in the delivery of vaccines)
Delays occurred in the implementation of the health component, which finally started
in June 2001. Therefore, when the first follow-up survey was realised in October 2001,
the beneficiaries had been receiving the transfers for the education component for 13
months and those for the health and nutrition component for 5 months only
Participants: All households except 169 (2.9%of households that lived in the intervention
area) that owned either a vehicle (truck, pickup truck, or jeep) or land >14.1 hectares or
both
Interventions INTERVENTION: in 21 clusters
Programme had 2 components:
1. monthly “food security” cash transfer (“bono alimentario” = USD224 per year =
13% of total amount of household expenditures in beneficiary households before the
programme) conditional on attendance at monthly health educational workshops, on
bringing their children under age 5 years for free scheduled preventive childcare
appointments (which included the provision of anti-parasitic medication, and vitamins
and iron supplements), on having up-to-date vaccination, and on adequate weight gain.
2. A “school attendance” cash transfer every 2 months (USD112 per year = 8% of
total amount of household expenditures in beneficiary households), contingent on
enrolment and regular school attendance of children aged 7-13 years. In addition,
household received an annual cash transfer per eligible child for school supplies
Beneficiaries did not receive the food or education cash transfers if they failed to comply
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with any of the conditions
CONTROL: no intervention in the 21 control clusters
Outcomes Immunisation coverage: reported up-to-date vaccination schedule (children aged 12-23
months)
Health services uptake: attendance of preventive care visits by children
Anthropometric or nutritional outcomes: prevalence of stunting, wasting, and under-
weight (children aged < 5 years)
Height for age Z-score (children aged < 5 years)
Prevalence of anaemia
Duration of intervention 5 years
Notes The “Red de Proteccion Social” project was financed by a loan from the Inter-American
Development Bank. The impact analysis of the pilot phase was done by the International
Food Policy Research Institute
Possible detection of the “Hawthorne effect” since performance of the programme was
slightly lower the second year
Over the 2 years, the actual mean monetary transfer to households represented 18% of
total household expenditure (similar to PROGRESA but 5 times larger than Programa
de Asignación Familiar). The nominal transfers remained constant during the 2 years of
the programme, thus the real value of the transfer declined by 8% due to inflation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random selection by balloting within
each stratum, randomisation was achieved
by blindly drawing one of six coloured balls
(three blue for intervention, three white for
control) from a box after the name of each
comarca [region] was called out”
Allocation concealment (selection bias) High risk Randomisation not concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk Study not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Reasons for attrition not given
Selective reporting (reporting bias) Unclear risk Unclear if all outcomes stated in the proto-
col were reported on
Other bias High risk “In October 2001, then, beneficiaries had
been receiving transfers, and the educa-
tional components of the program had
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been monitored for 13 months, but they
had only received five months of the health
and nutrition services, including the health
education workshops”
“It is important to emphasize that for most
of the indicators considered, the control
group also showed large improvements over
the period, although on a much smaller
scale. A possible explanation for this in-
crease is that other providers are bringing
health services into the areas not covered
by the program (program providers do not
offer or deliver any services to non-benefi-
ciaries)”
Baseline outcome measurements similar? Unclear risk Baseline number of children aged 12-23
months with updated immunisation simi-
lar between baseline and control
Baseline characteristics similar? Unclear risk Baseline characteristics on the intervention
and control groups not stated. Author re-
ported “few significant difference between
households (or individuals) in intervention
and control groups at baseline” but was un-
clear if the difference were related to out-
comes of the review
Adequate protection against contamina-
tion?
High risk “Control and intervention comarcas [re-
gions] are at times adjacent to one another.
A household may be a beneficiary while
its neighbour is a nonbeneficiary, particu-
larly in a few cases where boundaries such
as roads divide two comarcas. Seeing the
activity and the emphasis placed on the
RPS objectives may lead non-beneficiaries
to undertake behavior they would not have
otherwise. Reasons for such actions could
be many - including the possibility that the
individuals thought this was a way to be-
come eligible”
Morris 2004
Methods Cluster RCT in Honduras
Participants Participants: households in 70 clusters including pregnant women, new mothers, and
children aged < 3 years. Outcome on immunisation was measured in 4359 children at
pre-intervention and 3876 at post-intervention
Aim: to drive demand, poor households benefited from cash transfer on the condition
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that they keep up-to-date with preventive healthcare services
Interventions Intervention A: household monetary incentive in 20 clusters: consisted of distribution of
vouchers worth GBP2.53 to mothers who were registered in 2000 census who were
either pregnant or had a child < 3 years of age to a maximum of 2 children. In addition,
mothers with children aged 6-12 years enrolled in primary schools in grade 1-4 given
vouchers worth GBP3.69 per month. Beneficiaries lost aid if they were not up-to-date
with routine antenatal care, and well-child preventive health care and if child did not
attend school regularly
Intervention B: service-level monetary incentive in 10 clusters: quality assurance teams set
up at each health centre and trained on basic quality assurance methods. They developed
work plans that included minor structural repairs; purchase of equipment, materials,
and essential drugs; and money to pay lay assistants. Package included promotion of
community-based nutrition programme for children aged < 2 years
Intervention C: combination of household and service-level monetary incentives (i.e.
Interventions A + B) in 20 clusters
Control: standard (routine) care in 20 clusters
Outcomes Proportion of pregnant women immunised against tetanus
Proportion of children aged 93 days to 3 years who received first dose of DTP or pen-
tavalent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type B, hepatitis
B) at 42-92 days of age
Proportion of children aged 1 year old immunised against measles
Duration of intervention 1 year
Notes 2 years of follow up.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Children made to pick coloured balls from a box where
aperture would not allow the children to see the ballot balls
Allocation concealment (selection bias) High risk “From the day of the randomisation onwards, there was no
attempt to conceal the allocation, but it was not possible for
a household to become eligible for the vouchers by moving
into a beneficiary municipality. On the other hand, it was
not possible to restrict usage of ’improved’ health services
to residents of the appropriate municipality”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Loss to follow up did not exceed 5%”
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Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias High risk Service package could not be provided according to the
protocol and training on quality assurance was limited to
only the introduction. Disbursement of funds for this was
only 17% of the budget
Unit of randomisation was municipalities. Analysis not
adjusted for cluster effect
Baseline outcome measurements similar? High risk The coverage of DTP1 vaccine in the group receiving in-
tervention C (intervention A + B) was lower than the other
3 groups
Baseline characteristics similar? Low risk Demographic and socioeconomic data of the 4 groups sim-
ilar
Adequate protection against contamina-
tion?
High risk It was possible for participants from other arms of study to
attend services at improved centres. 14% of children aged
< 3 years attended clinics in municipalities other than their
municipality of residence 1 month prior to post-interven-
tion survey
Owais 2011
Methods RCT in Pakistan
Participants Setting: urban and semi-urban communities with low literacy and low immunisation
coverage
Participants: 364mother-infant pairs, with infants aged≤ 6weeks. Excluded twin births,
infants > 6 weeks of age, or infants born to mothers living outside the study surveillance
areas. Cut-off of 6 weeks used to ensure that the intervention was implemented before
the first dose of DTP/hepatitis B became due
Interventions Intervention: 3 targeted pictorial messages regarding vaccines administered by trained
CHWs. First key message highlighted how vaccines save children’s lives. Second message
provided logistic information about the address and location of the local vaccination
centres. Third key message emphasised the significance of retaining immunisation cards,
and role they could play at the time of the child’s school admissions. Copy of these
pictorial messages was left with the mother. Messages took about 5 minutes to impart
Control: verbal general health promotion messages delivered by trained CHWs. Mes-
sages included information on handwashing, breastfeeding, cleanwater, benefits of using
oral rehydration solutions during diarrhoea, bringing the infant to nearby health centre
when there were symptoms of acute respiratory illnesses, importance of antenatal check-
ups for mothers, and some general information on vaccines. Length of each educational
session was approximately 10-15 minutes
Outcomes DTP/hepatitis B vaccine completion (3 doses) at 4 months after enrolment (4-5 months
of infant’s age)
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Duration of intervention 4 months
Notes Community-based study conducted at 5 low-income sites in Karachi, Pakistan. Partic-
ipants were enrolled from August 2008 to November 2008 and followed up for assess-
ment of outcome from December 2008 to March 2009, with each individual mother-
infant pair approached 4 months after the educational intervention session
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization lists, stratified for each of the five enrolment
sites were generated by a computer and provided to the CHWs.
Upon consent, mother-infant pairs were assigned either to in-
tervention or control arms through block randomisation (n = 4)
, according to the computer-generated list”
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
Low risk “As the intervention was educational, blinding of study staff and
participantswas not possible...Outcome assessmentwas done by
an investigator ... blinded to the exposure status of participants”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data not available for 2% (4/183) in the intervention
group (0 deaths) and 3% (5/183) in the control group (3 deaths)
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias Low risk None
Baseline outcome measurements similar? Low risk Yes
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Low risk Yes
Pandey 2007
Methods Cluster RCT in India
Participants Setting: community-based trial
Aim: tested the hypothesis that informing the community will enhance accountability
of the health workers towards quantity and quality of services rendered. Resource poor
rural populations were informed about entitled services
Participants: households with at least 1 child going to public primary school in the village.
Immunisation coverage targeted children aged 0-35 months. 1025 children included
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Interventions Intervention: information campaign in 11 clusters; 2 rounds of information campaigns
consisting of 2 or 3 meetings and distribution of posters and leaflets. 15-minute au-
diotaped message played twice at each meeting and 15 minutes given for questions.
To ensure uniformity only questions for which answers were written in the leaflet were
responded to
Control: no intervention in 10 control clusters
Outcomes Received tetanus vaccination
Received at least 1 vaccine
Duration of intervention Each of the 2 rounds of meetings lasted for 1 hour and each round was separated by 2
weeks
Notes Post-intervention data collected 12 months after
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly generated numbers
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Low risk Research assistants at post-intervention had no knowledge of
the intervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2.4% loss to follow-up
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias High risk Proportion at campaign meetings 11-14% and long recall pe-
riod
Unit of study was village; unit of analysis was household. No
adjustment for clustering effect
Baseline outcome measurements similar? Low risk Difference between proportion of children immunised at base-
line in the 2 groups was not statistically significant
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Unclear risk “By randomly selecting only 5 village clusters of about 1000 in
each district, we spread the selection of 105 village clusters over
21 districts to minimize any potential for contamination”
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Methods Matched, cluster RCT in 10 sites in Manicaland, Zimbabwe
Participants Aim: tested effect of conditional and unconditional cash transfer among poor and vul-
nerable populations in Zimbabwe
Setting and participants: “We ranked households according to their index score and
then divided them into quintiles in each study site, thus identifying the poorest 20% of
households in each site... Eligible households contained children younger than 18 years
and satisfied at least one other criteria: head of household was younger than 18 years;
household cared for at least one orphan younger than 18 years, a disabled person, or an
individual who was chronically ill; or household was in poorest wealth quintile
Households within the clusters were eligible for inclusion in the trial when they contained
children younger than 18 years and satisfied at least one other criteria at baseline: the
head of the household was younger than 18 years; the household cared for at least one
orphan (a child younger than 18 years with one or more deceased parents), disabled
person, or an individual who was chronically ill; or the household was in the poorest
wealth quintile. Households in the richest wealth quintile and those already receiving
cash transfers for orphans and vulnerable children were not eligible
We did a baseline survey of all households in the trial clusters between July, and Septem-
ber, 2009. We counted how many members made up each household and obtained
information about trial endpoints and eligibility and exclusion criteria, including house
hold asset data. We constructed a wealth index with a simple sum of reported household
assets (appendix). We ranked households according to their index score and then divided
them into quintiles in each study site, thus identifying the poorest 20% of households in
each site. We obtained informed consent from the most senior member of the household
available at time of interview”
Interventions Intervention: unconditional cash transfers in 1525 households, conditional cash trans-
fers in 1319 households
“Every household enrolled in the UCT [unconditional cash transfer] programme col-
lected US$ [USD] 18 plus $4 per child in the household (up to a maximum of three
children) from designated pay points every 2 months
Households in theCCT[conditional cash transfer] group could receive the same amount,
but were monitored for compliance with several conditions: an application for a birth
certificate had to be made within 3 months for all children younger than 18 years
(including newborn babies) whose births had not been registered; children younger than
5 years had to be up-to-date with vaccinations and attend growth monitoring clinics
twice a year; children aged 6-17 years had to attend school at least 90% of the time
per month; and a representative from every household had to attend two-thirds of local
parenting skills classes. Compliance cards were issued to CCT households and were
signed by service providers when beneficiaries accessed services. The signed cards were
brought to the pay points every 2 months, along with other documents such as birth
certificates, child health cards, and receipts for the payment of school fees. Community
committees were familiar with most people living in the trial clusters. If a household
provided a good reason for not meeting conditions (e.g. a child missing school because
of illness), it was verified by the committee and judged on a case-by-case basis”
Control: no intervention in 1199 households
Outcomes 3 domains of child well-being (identity, health, and education)
Proportion of children aged < 5 years with a birth certificate
Proportion of children aged < 5 years with up-to-date vaccinations (measles, BCG, polio,
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Robertson 2013 (Continued)
and DTP)
Proportion of children aged 6-12 years attending school at least 80% of the time in the
previous month
Duration of intervention 13 months
Notes “After the baseline survey, clusters were randomly assigned to UCT [unconditional
cash transfer], CCT [conditional cash transfer], or control at public meetings that any
community members could attend. In each site, one cluster was assigned to UCT, one
to CCT, and one to control. Allocation was done by the drawing of lots from a hat.
Participating households and individuals delivering the intervention were not masked
to cluster assignment
At follow-up, research assistants were not told the allocation of the household they were
interviewing, but questions were included at the end of the questionnaire about whether
households received transfers. LR was masked when doing the primary analysis”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation through balloting
Allocation concealment (selection bias) High risk Randomisation not concealed
Blinding (performance bias and detection
bias)
All outcomes
Low risk Study was single blinded. “LR was masked
while doing the primary analysis”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Lost to follow-up accounted for and anal-
ysis was by intension to treat
Selective reporting (reporting bias) Unclear risk Study protocol not available
Other bias Unclear risk 2 villages randomised into the control
group were mistakenly enrolled in the un-
conditional cash transfer group. Duration
of study was shortened from 24 to 13
months due to lack of funds
Baseline outcome measurements similar? Low risk Yes
Baseline characteristics similar? High risk Some characteristics were dissimilar
Adequate protection against contamina-
tion?
High risk Almost one-third of those for UCT re-
ported having to comply with conditions
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Usman 2009
Methods RCT in Pakistan
Participants Setting: reminder intervention in an urban setting in Pakistan to reduce drop-out rate
in DTP3
Participants: 375 mothers visiting the EPI centre in each of 4 arms of study with 1125
children registering for DTP1 immunisation and residing in the study area for the past
6 months
Interventions Intervention A: redesigned (“reminder-type”) immunisation card; a larger card (15.5 cm by
11.5 cmwhen folded) that had only the date and day of next immunisation on both sides
of the outer card printed with Microsoft Word font size 42 was designed as a reminder
for mothers/carers for immunisation. Inner side of the card contained information about
the child’s complete immunization schedule dates and instructions for the mother/carer
For those in the arm for redesigned card, the date and day for each DTP vaccination
was written on the outer side of the card; dates of previous vaccinations were crossed out
to avoid confusion. Mother was advised to place the card at a frequently visible place at
home and to bring it to the clinic during immunisation visits
Intervention B: centre-base education; clinic-based education that lasted 2-3 minutes
given to mothers at enrolment of their children in the EPI centre. The health education
emphasised the importance of immunisation schedule completion
Intervention C: intervention 1 + 2
Control: standard care
Outcomes Number of enrolled children with DTP3 completed within 90 days of duration of study
Duration of intervention 2-3 minutes per session; follow-up for 90 days
Notes Urban Pakistan
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Allocation sequence was by computer-generated randomisation
list
Allocation concealment (selection bias) Unclear risk Unclear whether allocation was concealed
Blinding (performance bias and detection
bias)
All outcomes
High risk Neither the participant nor the assessor was blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias Low risk No other bias detected
Baseline outcome measurements similar? Low risk Not applicable
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Baseline characteristics similar? High risk Most of the socioeconomic variables were similar but ownership
of a television was more among group receiving education and
a higher proportion of those receiving standard care lived close
to the facility than those in the redesigned card group
Adequate protection against contamina-
tion?
Unclear risk Unclear
Usman 2011
Methods RCT in Pakistan
Participants Setting: rural setting in Pakistan
Aim: to test theory that reminder intervention can reduce drop-out rate for DTP3
vaccination
Participants: 1508 mother-child pair visiting selected EPI centres for DTP1 who were
resident in study area for at least 6 months. Criterion used to exclude 2 groups of
temporary residents: womenwho temporarily relocated to theirmothers’ houses to deliver
their children and internally displaced families who had migrated to the study area to
avoid the aftermath of 2005 earthquake in the north of Pakistan
Interventions Intervention A: redesigned (“reminder-type”) immunisation card; a larger card than the
existing EPI card (15.5 cm by 11.5 cm when folded), placed in a plastic jacket and
provided with a hanging string. A “trained interviewer pasted the upcoming date and
day of DTP2 immunization on both outer sides of the card and showed it to the mother.
Mother was asked to hang the card in her home at a frequently visible place and requested
that she bring the card along on her next immunization visit to the EPI centre. At DTP2
visit, the interviewer crossed out the date and day for DTP2 visit to avoid any confusion
to the mothers, pasted the date and day for the upcoming DTP3 immunization visit on
both sides of the card and showed the information to the mother.” The inner side of
the card contained information about the child’s complete immunisation schedule dates
and instructions for the mother
Intervention B: centre-base education; 2- to 3-minute conversation between trained
study interviewer andmother to convey the importance of completing the immunisation
schedule and the potential adverse impact of incomplete immunisation on the child’s
health. Session was in simple vocabulary in the local language and deliberately kept short
in prevision of potential large-scale use by EPI staff in the future
Intervention C: combination of redesigned card and centre-based education
Control: standard care i.e. routine EPI centre visit and neither intervention
Outcomes DTP3 coverage at the end of day 90 post-enrolment.
Duration of intervention 2-3 minutes per session; follow-up at 90 days
Notes Rural areas around Karachi, Pakistan. Despite a small purchase volume, the cost of each
card including the plastic jacket was USD0.05
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The lead investigator provided a computer-generated randomi-
sation list to each enrolment centre”
Allocation concealment (selection bias) Unclear risk “Each enrolled mother-child pair received an identification
number (ID) from the randomisation list and was assigned to
the study group corresponding to the ID on the list”
Blinding (performance bias and detection
bias)
All outcomes
High risk “Because of the overt nature of interventions, neither the study
participants nor the interviewers enrolling the study participants
and recording the study outcome were blinded to the type of
intervention received by the study participants”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Unclear risk Unclear what outcomes were stated in the protocol
Other bias Low risk No other bias detected
Baseline outcome measurements similar? Low risk Not applicable
Baseline characteristics similar? Low risk Yes
Adequate protection against contamina-
tion?
Low risk “Interventions were provided in a private space to prevent con-
tamination between study groups”
BCG: Bacille Calmette-Guérin; CHW: community health worker; DTP: diphtheria-tetanus-pertussis; EPI: Expanded Programme
on Immunization; HBV3: three doses of hepatitis B virus; OPV: oral polio vaccine; PHC: primary healthcare; RCT: randomised
controlled trial; WHO: World Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abdul Rahman 2013 A controlled before-and-after study with single unit for intervention and control arms
al Teheawy 1992 Retrospective study
Alto 1989 Observational study
Aneni 2013 Observational study
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Anjum 2004 A controlled before-and-after study with single unit for intervention and control arms
Attanasio 2005 No relevant data on outcome
Balraj 1986 Programme evaluation
Bandyopadhyay 1996 Observational study
Barham 2009 Programme evaluation
Bazos 2015 No relevant data on outcome
Berhane 1993 No relevant outcome. Reports on drop-out rate
Berman 1991 Observational study
Berry 1991 Observational study
Bishai 2002 No relevant data on outcome
Chandir 2010 Observational study
Chen 1976 Retrospective study
Chen 1989 Observational study
Cutts 1990 Observational study
Cutts 1994 Observational study
Dammann 1990 Observational study
Dini 1995 No relevant data on outcome
Dominguez Ugá 1988 Observational study
Ekunwe 1984 Observational study
Gomber 1996 Observational study
Hayford 2014 Observational study
Hong 2005 Observational study
Hu 2015 A controlled before-and-after study with single unit for intervention and control arms
Igarashi 2010 A controlled before-and-after study with single unit for intervention and control arms
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Kaewkungwal 2015 Observational study
Kuhn 1990 Observational study
Kumar 1990 Observational study
Lechtig 1981 A controlled before-and-after study with single unit for intervention and control arms
Lin 1971 Observational study
Linkins 1995 Observational study
Maher 1993 Observational study
Main 2001 Observational study
Marshall 2007 Retrospective study
Ndiritu 2006 Observational study
Osinka 2000 Observational study
Pan 1999 Observational study
Pierce 1996 A controlled before-and-after study with single unit for intervention and control arms
Prinja 2010 A controlled before-and-after study with single unit for intervention and control arms
Przewlocka 2000 Observational study
Robinson 2001 Observational study
Ryman 2011 Data not summarised by the study groups
San Sebastian 2001 Observational study
Shaikh 2003 Observational study
Sutanto 1999 Observational study
Uddin 2010 A controlled before-and-after study with single unit for intervention and control arms
Uddin 2012 Study had no control arm
Uskun 2008 Observational study
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van Zwanenberg 1988 Observational study
Wang 2007 No relevant outcome for the review
Zimicki 1994 Observational study
Characteristics of studies awaiting assessment [ordered by study ID]
Ali 2015
Methods A quasi-experimental study in rural Pakistan
Participants Household heads
Interventions Community service in intervention clusters (government Basic Health unit) versus standard care in control clusters
Outcomes Knowledge and practices regarding routine immunisation,
Fully vaccinated children, partially vaccinated children, un-vaccinated children
Notes
Bangure 2015
Methods Randomised controlled trial in Kadoma City, Zimbabwe
Participants Women at delivery
Interventions SMS reminders versus standard care
Outcomes Immunisation coverage, timely vaccinations
Notes
Basinga 2011
Methods Cluster RCT in Rwanda
Participants Healthcare providers
Interventions Performance-based payment of healthcare providers (payment for performance; P4P) versus traditional input-based
funding
Outcomes Immunisation, prenatal care visits and institutional deliveries, quality of prenatal care, and child preventive care visits
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Notes
Briere 2012
Methods controlled before-after study in rural Kenya
Participants Caregivers of children aged 2-13 months
Interventions Free hygiene kits and education about water treatment and hand hygiene
Outcomes Fully vaccinated children
Notes
Brown 2016
Methods Cluster RCT in Ibadan, Nigeria
Participants Children aged 0-12 weeks
Interventions Mobile phone reminders and recall versus Primary Health Care immunisation providers’ training versus combined
Mobile phone reminders and recall versus Primary Health Care immunisation providers’ training versus standard care
Outcomes Children fully vaccinated at 12 months of age
Notes
Busso 2015
Methods A field experiment in rural Guatemala
Participants Families whose children were due for a vaccine
Interventions Personal reminders versus standard care
Outcomes Fully vaccinated children
Notes
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Domek 2016
Methods RCT in Guatemala City
Participants Caregivers of infants aged 8-14 weeks presenting for first dose of primary immunisation series
Interventions Mobile phone short message service versus standard care
Outcomes Fully vaccinated infants
Notes
Gokcay 1993
Methods Random allocation of paraprofessionals and Midwives to “visiting area” in Istanbul, Turkey
Participants Midwives and lady home visitors (paraprofessionals) and children aged < 5 years
Interventions Use of lay home visitors vs. midwives for home visit
Outcomes Infants fully vaccinated, children aged < 5 fully vaccinated
Notes
Haji 2016
Methods Random allocation of three facilities in three districts in Kenya to two interventions and control
Participants children less than 12 months
Interventions Reminder text message vs reminder sticker
Outcomes Receipt of DTP 2 and DTP 3 at 10 and 14 weeks; dropout rate
Notes
Johri 2015a
Methods Cluster RCT in rural Uttar Pradesh, India
Participants Mothers of children 0-23 months of age were eligible
Interventions Home visits by volunteers plus community mobilisation to promote immunisation versus community mobilisation
to promote nutrition
Outcomes Primary outcomes were feasibility of recruitment, randomisation and retention of participants
Notes
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Linkins 1994
Methods Randomised controlled trial
Participants Children aged < 2 years, had telephone numbers listed in pre-exiting computerised database, and were due or late
for immunisation(s) during the 4-month enrolment period
Interventions Household of children were randomised to receive or not receive a general or vaccine-specific computer generated
telephone reminder message 1 day before the child was due, or immediately after randomisation if the child was late
Outcomes The rate of immunisation visits in the 30-day follow-up period
Notes
Uddin 2016
Methods Non randomised trial in urban and rural Bangladesh
Participants Families of children in need of vaccination
Interventions Mobile phone short message service versus standard care
Outcomes Fully vaccinated children
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Health education
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Measles vaccine 1 Risk Ratio (Random, 95% CI) Totals not selected
2 DTP3 5 Risk Ratio (Random, 95% CI) Subtotals only
2.1 Community-based
education
2 Risk Ratio (Random, 95% CI) 1.68 [1.09, 2.59]
2.2 Facility-based education 3 Risk Ratio (Random, 95% CI) 1.20 [0.97, 1.48]
3 Received at least 1 vaccine 1 Risk Ratio (Random, 95% CI) Totals not selected
Comparison 2. Health education plus redesigned reminder card
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 DTP3 2 Risk Ratio (Random, 95% CI) 1.50 [1.21, 1.87]
Comparison 3. Household monetary incentive
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Measles 1 Risk Ratio (Random, 95% CI) Totals not selected
2 Fully immunised children 2 Risk Ratio (Random, 95% CI) 1.05 [0.90, 1.23]
3 BCG 1 Risk Ratio (Random, 95% CI) Totals not selected
4 MMR 1 Risk Ratio (Random, 95% CI) Totals not selected
4.1 Household monetary
incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Service-level monetary
incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
4.3 Household + service-level
monetary incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
5 DTP1 1 Risk Ratio (Random, 95% CI) Totals not selected
5.1 Household monetary
incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
5.2 Service-level monetary
incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
5.3 Household + service-level
monetary incentive
1 Risk Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 4. Home visit
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 OPV3 1 Risk Ratio (Random, 95% CI) Totals not selected
2 Measles 1 Risk Ratio (Random, 95% CI) Totals not selected
Comparison 5. Regular immunisation outreach
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fully immunised children 1 Risk Ratio (Fixed, 95% CI) Totals not selected
1.1 Regular immunisation
outreach only
1 Risk Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Regular immunisation
outreach + incentive
1 Risk Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 6. Integration of immunisation to other health services
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 BCG 1 Risk Ratio (Random, 95% CI) Totals not selected
2 DTP3 1 Risk Ratio (Random, 95% CI) Totals not selected
3 Measles 1 Risk Ratio (Random, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Health education, Outcome 1 Measles vaccine.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 1 Health education
Outcome: 1 Measles vaccine
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Andersson 2009 0.4889 (0.2347) 1.63 [ 1.03, 2.58 ]
0.01 0.1 1 10 100
Favours standard care Favours health education
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Analysis 1.2. Comparison 1 Health education, Outcome 2 DTP3.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 1 Health education
Outcome: 2 DTP3
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 Community-based education
Andersson 2009 0.7734 (0.2124) 43.2 % 2.17 [ 1.43, 3.29 ]
Owais 2011 0.3293 (0.1355) 56.8 % 1.39 [ 1.07, 1.81 ]
Subtotal (95% CI) 100.0 % 1.68 [ 1.09, 2.59 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 3.11, df = 1 (P = 0.08); I2 =68%
Test for overall effect: Z = 2.37 (P = 0.018)
2 Facility-based education
Bolam 1998 0.01 (0.0327) 36.1 % 1.01 [ 0.95, 1.08 ]
Usman 2009 0.1655 (0.0603) 33.4 % 1.18 [ 1.05, 1.33 ]
Usman 2011 0.4055 (0.083) 30.5 % 1.50 [ 1.27, 1.77 ]
Subtotal (95% CI) 100.0 % 1.20 [ 0.97, 1.48 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 21.95, df = 2 (P = 0.00002); I2 =91%
Test for overall effect: Z = 1.69 (P = 0.090)
Test for subgroup differences: Chi2 = 1.91, df = 1 (P = 0.17), I2 =48%
0.2 0.5 1 2 5
Favours standard care Favours health education
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Analysis 1.3. Comparison 1 Health education, Outcome 3 Received at least 1 vaccine.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 1 Health education
Outcome: 3 Received at least 1 vaccine
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Pandey 2007 0.3577 (0.3536) 1.43 [ 0.72, 2.86 ]
0.01 0.1 1 10 100
Favours standard care Favours inform campaign
Analysis 2.1. Comparison 2 Health education plus redesigned reminder card, Outcome 1 DTP3.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 2 Health education plus redesigned reminder card
Outcome: 1 DTP3
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Usman 2009 0.3075 (0.0544) 55.3 % 1.36 [ 1.22, 1.51 ]
Usman 2011 0.5306 (0.091) 44.7 % 1.70 [ 1.42, 2.03 ]
Total (95% CI) 100.0 % 1.50 [ 1.21, 1.87 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 4.43, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 3.67 (P = 0.00024)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours standard care Favours education + card
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Analysis 3.1. Comparison 3 Household monetary incentive, Outcome 1 Measles.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 3 Household monetary incentive
Outcome: 1 Measles
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Barham 2005 0 (0.191) 1.00 [ 0.69, 1.45 ]
0.01 0.1 1 10 100
Favours standard care Favours monetary incentive
Analysis 3.2. Comparison 3 Household monetary incentive, Outcome 2 Fully immunised children.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 3 Household monetary incentive
Outcome: 2 Fully immunised children
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Maluccio 2004 0.0296 (0.1117) 50.1 % 1.03 [ 0.83, 1.28 ]
Robertson 2013 0.077 (0.112) 49.9 % 1.08 [ 0.87, 1.35 ]
Total (95% CI) 100.0 % 1.05 [ 0.90, 1.23 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.09, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours standard care Favours cash transfer
68Interventions for improving coverage of childhood immunisation in low- and middle-income countries (Review)
Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 3.3. Comparison 3 Household monetary incentive, Outcome 3 BCG.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 3 Household monetary incentive
Outcome: 3 BCG
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Barham 2005 -0.0202 (0.3766) 0.98 [ 0.47, 2.05 ]
0.01 0.1 1 10 100
Favours standard care Favours monetary incentive
Analysis 3.4. Comparison 3 Household monetary incentive, Outcome 4 MMR.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 3 Household monetary incentive
Outcome: 4 MMR
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 Household monetary incentive
Morris 2004 -0.0565 (0.0654) 0.95 [ 0.83, 1.07 ]
2 Service-level monetary incentive
Morris 2004 0.0554 (0.0761) 1.06 [ 0.91, 1.23 ]
3 Household + service-level monetary incentive
Morris 2004 0.1034 (0.0584) 1.11 [ 0.99, 1.24 ]
0.5 0.7 1 1.5 2
Favours standard care Favours monetary incentive
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Analysis 3.5. Comparison 3 Household monetary incentive, Outcome 5 DTP1.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 3 Household monetary incentive
Outcome: 5 DTP1
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 Household monetary incentive
Morris 2004 0.0905 (0.0799) 1.09 [ 0.94, 1.28 ]
2 Service-level monetary incentive
Morris 2004 0.0025 (0.0941) 1.00 [ 0.83, 1.21 ]
3 Household + service-level monetary incentive
Morris 2004 0.1414 (0.0887) 1.15 [ 0.97, 1.37 ]
0.2 0.5 1 2 5
Favours standard care Favours monetary incentive
Analysis 4.1. Comparison 4 Home visit, Outcome 1 OPV3.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 4 Home visit
Outcome: 1 OPV3
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Brugha 1996 0.1989 (0.0651) 1.22 [ 1.07, 1.39 ]
0.2 0.5 1 2 5
Favours standard care Favours home visit
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Analysis 4.2. Comparison 4 Home visit, Outcome 2 Measles.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 4 Home visit
Outcome: 2 Measles
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Brugha 1996 0.2311 (0.0766) 1.26 [ 1.08, 1.46 ]
0.2 0.5 1 2 5
Favours standard care Favours home visit
Analysis 5.1. Comparison 5 Regular immunisation outreach, Outcome 1 Fully immunised children.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 5 Regular immunisation outreach
Outcome: 1 Fully immunised children
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Regular immunisation outreach only
Banerjee 2010 1.1282 (0.3093) 3.09 [ 1.69, 5.67 ]
2 Regular immunisation outreach + incentive
Banerjee 2010 1.8961 (0.2688) 6.66 [ 3.93, 11.28 ]
0.02 0.1 1 10 50
Favours standard care Favours outreach
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Analysis 6.1. Comparison 6 Integration of immunisation to other health services, Outcome 1 BCG.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 6 Integration of immunisation to other health services
Outcome: 1 BCG
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Dicko 2011 0.0296 (0.0747) 1.03 [ 0.89, 1.19 ]
0.01 0.1 1 10 100
Favours standard care Favours integration
Analysis 6.2. Comparison 6 Integration of immunisation to other health services, Outcome 2 DTP3.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 6 Integration of immunisation to other health services
Outcome: 2 DTP3
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Dicko 2011 0.6523 (0.1526) 1.92 [ 1.42, 2.59 ]
0.01 0.1 1 10 100
Favours standard care Favours integration
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Analysis 6.3. Comparison 6 Integration of immunisation to other health services, Outcome 3 Measles.
Review: Interventions for improving coverage of childhood immunisation in low- and middle-income countries
Comparison: 6 Integration of immunisation to other health services
Outcome: 3 Measles
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Dicko 2011 0.1222 (0.0316) 1.13 [ 1.06, 1.20 ]
0.01 0.1 1 10 100
Favours standard care Favours integration
A D D I T I O N A L T A B L E S
Table 1. Interventions to improve vaccination uptake and how they work
Target Interventions Purpose of the interventions
Recipients Communication interventions to informand educate tar-
geting individuals, groups, communities or providers, or
a combination of these through face-to-face interaction,
use of mass media, printed material, etc
To improve understanding on vaccination; its relevance;
benefits and risks of vaccination; where, when, and how
to receive vaccine services; andwho should receive vaccine
services (Willis 2013)
Communication interventions to recall or remind using
face-to-face interaction, telephone, mail, etc
To remind those who are overdue for vaccination in order
to reduce drop-out rate (Willis 2013)
Communication interventions to teach skills, e.g. parent-
ing skills
To provide people with the ability to operationalise
knowledge through the adoption of practical skills (Willis
2013)
Communication interventions to provide support To provide assistance or advice for consumers (Willis
2013)
Interventions to facilitate decision-making, e.g. decision
aids on vaccination for parents
To assist carers in participating in decision making (Dubé
2013)
Interventions to enable communication through tradi-
tional media, internet, etc
To make communication possible (Dubé 2013)
Interventions, including communication, to enhance
community ownership, e.g. community dialogues involv-
ing traditional and religious rulers
To increase demand for vaccination
To ensure sustainability
To build trust in vaccination and vaccination services
To drive demand for vaccination
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Table 1. Interventions to improve vaccination uptake and how they work (Continued)
Incentives To reward service uptake; to cover out-of-pocket cost
Providers Training To improve knowledge on vaccination, to improve skills,
to improve attitudes to clients, to reduce missed oppor-
tunities for vaccination
Audit and feedback To ensure quality and client satisfaction with services
Supportive supervision To ensure quality and maintain standards, to reduce
missed opportunities for vaccination
Incentives To boost morale and enhance performance
Health system Infrastructural development, e.g. provision of health fa-
cilities, provision of road to improve access to health fa-
cilities
To ensure access to services
Logistic support To improve service quality service and so improve utili-
sation to ensure availability of services
Service delivery, e.g. outreach; home visits; integration of
vaccination with other services; guidelines/protocol for
vaccination; increased resources
Outreach to improve access to services
Home visits to remind parents about vaccination and
identify unimmunised children for immunisation
Integration to encourage vaccine uptake
Guidelines and protocols to ensure quality of services
Improved resources to ensure availability of services
Policy makers Advocacy for:
development of supporting policies,
increased funding of health services
To promote the development of policies to support vac-
cine uptake
To increase funding to the health sector
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL, Cochrane Library
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ID Search Hits
#1 MeSH descriptor: [Immunization] this term only 636
#2 MeSH descriptor: [Immunization Schedule] this term only 931
#3 MeSH descriptor: [Immunization, Secondary] this term only 756
#4 MeSH descriptor: [Immunotherapy, Active] this term only 109
#5 MeSH descriptor: [Mass Vaccination] this term only 76
#6 MeSH descriptor: [Immunization Programs] this term only 377
#7 MeSH descriptor: [Vaccination] this term only 2330
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7 4366
#9 MeSH descriptor: [Child] explode all trees 173
#10 MeSH descriptor: [Infant] explode all trees 14329
#11 MeSH descriptor: [Mothers] this term only 1195
#12 MeSH descriptor: [Women] this term only 253
#13 MeSH descriptor: [Pregnant Women] this term only 122
#14 #9 or #10 or #11 or #12 or #13 15639
#15 #8 and #14 369
#16 (immunization or immunisation or vaccination) next (pro-
gram* or rate* or coverage or adher*):ti
309
#17 (vaccinat* or revaccinat* or immunization or immunisation)
near/3 (child* or infant* or newborn* or neonat* or baby or
babies or kid or kids or toddler* orwomanorwomenormother
or mothers):ti,ab,kw
2183
#18 #15 or #16 or #17 2485
#19 (Africa or Asia or Caribbean or “West Indies” or “South Amer-
ica” or “Latin America” or “Central America”):ti,ab,kw
6277
#20 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
13336
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(Continued)
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brazil or Brasil or Bulgaria or
“Burkina Faso” or “Burkina Fasso” or “Upper Volta” or Bu-
rundi or Urundi or Cambodia or “Khmer Republic” or Kam-
puchea or Cameroon or Cameroons or Cameron or Camerons
or “Cape Verde” or “Central African Republic” or Chad or
Chile or China or Colombia or Comoros or “Comoro Islands”
or Comores or Mayotte or Congo or Zaire or “Costa Rica” or
“Cote d’Ivoire” or “Ivory Coast” or Croatia or Cuba or Cyprus
or Czechoslovakia or “Czech Republic” or Slovakia or “Slovak
Republic”):ti,ab,kw
#21 (Djibouti or “French Somaliland” or Dominica or “Domini-
can Republic” or “East Timor” or “East Timur” or “Timor
Leste” or Ecuador or Egypt or “United Arab Republic” or “El
Salvador” or Eritrea or Estonia or Ethiopia or Fiji or Gabon
or “Gabonese Republic” or Gambia or Gaza or Georgia or
Georgian or Ghana or “Gold Coast” or Greece or Grenada or
Guatemala or Guinea or Guam or Guiana or Guyana or Haiti
or Honduras or Hungary or India or Maldives or Indonesia
or Iran or Iraq or “Isle of Man” or Jamaica or Jordan or Kaza-
khstan or Kazakh or Kenya or Kiribati or Korea or Kosovo
or Kyrgyzstan or Kirghizia or “Kyrgyz Republic” or Kirghiz
or Kirgizstan or “Lao PDR” or Laos or Latvia or Lebanon or
Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,
kw
14788
#22 (Macedonia or Madagascar or “Malagasy Republic” or
Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi
or Nyasaland orMali or Malta or “Marshall Islands” orMauri-
tania or Mauritius or “Agalega Islands” or Mexico or Microne-
sia or “Middle East” or Moldova or Moldovia orMoldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
“Netherlands Antilles” or “New Caledonia” or Nicaragua or
Niger or Nigeria or “Northern Mariana Islands” or Oman or
Muscat or Pakistan or Palau or Palestine or Panama or Paraguay
or Peru or Philippines or Philipines or Phillipines or Phillip-
pines or Poland or Portugal or “Puerto Rico”):ti,ab,kw
7142
#23 (Romania or Rumania or Roumania or Russia or Russian or
Rwanda or Ruanda or “Saint Kitts” or “St Kitts” or Nevis or
“Saint Lucia” or “St Lucia” or “Saint Vincent” or “St Vincent”
or Grenadines or Samoa or “Samoan Islands” or “Navigator Is-
land” or “Navigator Islands” or “Sao Tome” or “Saudi Arabia”
or Senegal or Serbia or Montenegro or Seychelles or “Sierra
Leone” or Slovenia or “Sri Lanka” or Ceylon or “Solomon Is-
lands” or Somalia or Sudan or Suriname or Surinam or Swazi-
land or Syria or Tajikistan or Tadzhikistan or Tadjikistan or
8710
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(Continued)
Tadzhik or Tanzania or Thailand or Togo or “Togolese Repub-
lic” or Tonga or Trinidad or Tobago or Tunisia or Turkey or
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay
or USSR or “Soviet Union” or “Union of Soviet Socialist Re-
publics” or Uzbekistan or Uzbek or Vanuatu or “New He-
brides” orVenezuela orVietnamor “VietNam”or “West Bank”
or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia)
:ti,ab,kw
#24 (developing or less* next developed or “under developed” or
underdeveloped or “middle income” or low* next income or
underserved or “under served” or deprived or poor*) next
(countr* or nation* or population* or world):ti,ab,kw
3803
#25 (developing or less* next developed or “under developed” or
underdeveloped or “middle income” or low* next income) next
(economy or economies):ti,ab,kw
23
#26 low* next (gdp or gnp or “gross domestic” or “gross national”)
:ti,ab,kw
33
#27 (low near/3 middle near/3 countr*):ti,ab,kw 391
#28 (lmic or lmics or “third world” or “lami country” or “lami
countries”):ti,ab,kw
92
#29 (“transitional country” or “transitional countries”):ti,ab,kw 2
#30 (#19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #
27 or #28 or #29)
46313
#31 #18 and #30 in Trials 684
MEDLINE In-Process & Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to Present, Ovid
# Searches Results
1 Immunization/ 46749
2 Immunization Schedule/ 9187
3 Immunization, Secondary/ 7263
4 Immunotherapy, Active/ 2360
5 Mass Immunization/ 2518
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6 Immunization Programs/ 8340
7 Vaccination/ 68480
8 or/1-7 130272
9 exp Child/ 1663903
10 exp Infant/ 1006268
11 Mothers/ 32291
12 Women/ 13948
13 Pregnant Women/ 5684
14 or/9-13 2193372
15 8 and 14 31376
16 ((vaccinat* or revaccinat* or immunization or immunisation)
adj3 (child* or infant? or newborn? or neonat* or baby or babies
or kid? or toddler? or woman or women or mother?)).ti,ab
16445
17 ((immunization or immunisation or vaccination) adj (pro-
gram* or rate* or coverage or adher*)).ti
3812
18 15 or 16 or 17 41477
19 Developing Countries.sh,kf. 76483
20 (Africa or Asia or Caribbean or West Indies or South America
or Latin America or Central America).hw,kf,ti,ab,cp
207983
21 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brazil or Brasil or Bulgaria or
Burkina Faso or Burkina Fasso or Upper Volta or Burundi or
Urundi or Cambodia or Khmer Republic or Kampuchea or
Cameroon or Cameroons or Cameron or Camerons or Cape
Verde or Central African Republic or Chad or Chile or China
or Colombia or Comoros or Comoro Islands or Comores or
Mayotte or Congo or Zaire or Costa Rica or Cote d’Ivoire or
Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia
or Czech Republic or Slovakia or Slovak Republic or Djibouti
3140964
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or French Somaliland or Dominica or Dominican Republic or
East Timor or East Timur or Timor Leste or Ecuador or Egypt
or United Arab Republic or El Salvador or Eritrea or Estonia or
Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or
Gaza or Georgia Republic or Georgian Republic or Ghana or
Gold Coast or Greece or Grenada or Guatemala or Guinea or
Guam or Guiana or Guyana or Haiti or Honduras or Hungary
or India or Maldives or Indonesia or Iran or Iraq or Isle of Man
or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiri-
bati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz
Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia
or Lebanon or Lesotho or Basutoland or Liberia or Libya or
Lithuania or Macedonia or Madagascar or Malagasy Republic
orMalaysia orMalaya orMalay or Sabah or Sarawak orMalawi
or Nyasaland or Mali or Malta or Marshall Islands or Mauri-
tania or Mauritius or Agalega Islands or Mexico or Microne-
sia or Middle East or Moldova or Moldovia or Moldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
Netherlands Antilles or New Caledonia or Nicaragua or Niger
or Nigeria or Northern Mariana Islands or Oman or Muscat
or Pakistan or Palau or Palestine or Panama or Paraguay or
Peru or Philippines or Philipines or Phillipines or Phillippines
or Poland or Portugal or Puerto Rico or Romania or Ruma-
nia or Roumania or Russia or Russian or Rwanda or Ruanda
or Saint Kitts or St Kitts or Nevis or Saint Lucia or St Lu-
cia or Saint Vincent or St Vincent or Grenadines or Samoa
or Samoan Islands or Navigator Island or Navigator Islands or
Sao Tome or Saudi Arabia or Senegal or Serbia or Montene-
gro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or
Ceylon or Solomon Islands or Somalia or Sudan or Suriname
or Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan
or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or
Togolese Republic or Tonga or Trinidad or Tobago or Tunisia
or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine
or Uruguay or USSR or Soviet Union or Union of Soviet So-
cialist Republics or Uzbekistan or Uzbek or Vanuatu or New
Hebrides or Venezuela or Vietnam or Viet Nam or West Bank
or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia)
.hw,kf,ti,ab,cp
22 ((developing or less* developed or under developed or under-
developed or middle income or low* income or underserved or
under served or deprived or poor*) adj (countr* or nation? or
population? or world)).ti,ab
68469
23 ((developing or less* developed or under developed or under-
developed or middle income or low* income) adj (economy or
economies)).ti,ab
343
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24 (low* adj (gdp or gnp or gross domestic or gross national)).ti,
ab
181
25 (low adj3 middle adj3 countr*).ti,ab. 6060
26 (lmic or lmics or third world or lami countr*).ti,ab. 4111
27 transitional countr*.ti,ab. 125
28 or/19-27 3294625
29 18 and 28 13577
30 randomized controlled trial.pt. 416221
31 controlled clinical trial.pt. 90701
32 pragmatic clinical trial.pt. 314
33 multicenter study.pt. 201344
34 non-randomized controlled trials as topic/ 57
35 interrupted time series analysis/ 145
36 controlled before-after studies/ 133
37 (randomis* or randomiz* or randomly allocat* or random al-
locat*).ti,ab
464168
38 groups.ab. 1550431
39 (trial or impact or effect or multicenter or multi center or mul-
ticentre or multi centre).ti
1074962
40 (intervention* or controlled or control group? or (before adj5
after) or (pre adj5 post) or pretest or pre test or posttest or post
test or quasiexperiment* or quasi experiment* or evaluat* or
time series or time point? or repeated measur*).ti,ab
3915143
41 or/30-40 5729695
42 exp Animals/ 20169765
43 Humans/ 15928724
44 42 not (42 and 43) 4241041
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45 review.pt. 2110328
46 meta analysis.pt. 65647
47 news.pt. 176635
48 comment.pt. 663297
49 editorial.pt. 401580
50 cochrane database of systematic reviews.jn. 12225
51 comment on.cm. 663297
52 (systematic review or literature review).ti. 73686
53 or/44-52 7292678
54 41 not 53 4229940
55 29 and 54 4680
CINAHL, EbscoHost
# Query Results
S54 S16 AND S34 AND S52 [Exclude MEDLINE records] 119
S53 S16 AND S34 AND S52 780
S52 S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR
S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR
S49 OR S50 OR S51
940,212
S51 TI (randomis* or randomiz* or randomly or trial or effect* or
impact* or intervention* or multicenter or “multi center” or
multicentre or “multi centre” or controlled or groups or before
N5 after or pre N5 post or ((pretest or “pre test”) and (posttest
or “post test”)) or quasiexperiment* or quasi W0 experiment*
or pseudo experiment* or pseudoexperiment* or evaluat* or
“time series” or time W0 point* or repeated W0measur*) OR
AB (randomis* or randomiz* or randomly or trial or effect* or
impact* or intervention* or multicenter or “multi center” or
multicentre or “multi centre” or controlled or groups or before
N5 after or pre N5 post or ((pretest or “pre test”) and (posttest
or “post test”)) or quasiexperiment* or quasi W0 experiment*
or evaluat* or “time series” or time W0 point* or repeated W0
877,979
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measur*)
S50 (MH “Health Services Research”) 7,382
S49 (MH “Experimental Studies+”) 168,959
S48 (MH “Time Series”) 1,612
S47 (MH “Multiple Time Series”) 3
S46 (MH “Interrupted Time Series Analysis”) 11
S45 (MH “Repeated Measures”) 39,029
S44 (MH “Multicenter Studies”) 11,769
S43 (MH “Quasi-Experimental Studies”) 7,003
S42 (MH “Pretest-Posttest Design”) 26,485
S41 (MH “Pretest-Posttest Control Group Design”) 403
S40 (MH “Nonrandomized Trials”) 170
S39 (MH “Intervention Trials”) 5,990
S38 (MH “Clinical Trials”) 84,421
S37 (MH “Randomized Controlled Trials”) 26,420
S36 PT clinical trial 52,784
S35 PT randomized controlled trial 30,609
S34 S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR
S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR
S31 OR S32 OR S33
213,994
S33 TI transitional W0 countr* OR AB transitional W0 countr* 34
S32 TI ( lmic or lmics or third W0 world or lami W0 countr* )
OR AB ( lmic or lmics or third W0 world or lami W0 countr*
)
517
S31 TI low N3 middle N3 countr* OR AB low N3 middle N3
countr*
1,279
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S30 TI ( low* W0 (gdp or gnp or gross W0 domestic or gross
W0 national) ) OR AB ( low* W0 (gdp or gnp or gross W0
domestic or gross W0 national) )
16
S29 TI ( (developing or less*W0developed or underW0developed
or underdeveloped or middleW0 income or low*W0 income)
W0 (economy or economies) ) OR AB ( (developing or less*
W0 developed or under W0 developed or underdeveloped or
middle W0 income or low* W0 income) W0 (economy or
economies) )
46
S28 TI ( (developing or less* W0 developed or under W0 devel-
oped or underdeveloped or middle W0 income or low* W0
income or underserved or under W0 served or deprived or
poor*) W0 (countr* or nation or nations or population* or
world or area or areas) ) OR AB ( (developing or less* W0 de-
veloped or under W0 developed or underdeveloped or middle
W0 income or low* W0 income or underserved or under W0
served or deprived or poor*) W0 (countr* or nation or nations
or population* or world or area or areas) )
11,124
S27 MW ( Afghanistan or Bangladesh or Benin or “Burkina Faso”
or Burundi or Cambodia or “Central African Republic” or
Chad or Comoros or Congo or “Cote d’Ivoire” or Eritrea or
Ethiopia or Gambia or Ghana or Guinea or Haiti or India
or Kenya or Korea or Kyrgyz or Kyrgyzstan or Lao or Laos
or Liberia or Madagascar or Malawi or Mali or Mauritania or
Melanesia orMongolia orMozambique orBurmaorMyanmar
or Nepal or Niger or Nigeria or Pakistan or Rwanda or “Sa-
lomon Islands” or “Sao Tome” or Senegal or “Sierra Leone” or
Somalia or Sudan or Tajikistan or Tanzania or Timor or Togo
or Uganda or Uzbekistan or Vietnam or “Viet Nam” or Yemen
or Zambia or Zimbabwe ) or TI ( Afghanistan or Bangladesh or
Benin or “Burkina Faso” or Burundi or Cambodia or “Central
African Republic” or Chad or Comoros or Congo or “Cote
d’Ivoire” or Eritrea or Ethiopia or Gambia or Ghana or Guinea
or Haiti or India or Kenya or Korea or Kyrgyz or Kyrgyzstan
or Lao or Laos or Liberia or Madagascar or Malawi or Mali
or Mauritania or Melanesia or Mongolia or Mozambique or
Burma or Myanmar or Nepal or Niger or Nigeria or Pakistan
or Rwanda or “Salomon Islands” or “Sao Tome” or Senegal
or “Sierra Leone” or Somalia or Sudan or Tajikistan or Tan-
zania or Timor or Togo or Uganda or Uzbekistan or Vietnam
or “Viet Nam” or Yemen or Zambia or Zimbabwe ) or AB (
Afghanistan or Bangladesh or Benin or “Burkina Faso” or Bu-
rundi or Cambodia or “Central African Republic” or Chad or
Comoros or Congo or “Cote d’Ivoire” or Eritrea or Ethiopia
or Gambia or Ghana or Guinea or Haiti or India or Kenya or
48,132
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Korea or Kyrgyz or Kyrgyzstan or Lao or Laos or Liberia or
Madagascar or Malawi or Mali or Mauritania or Melanesia or
Mongolia or Mozambique or Burma or Myanmar or Nepal or
Niger or Nigeria or Pakistan or Rwanda or “Salomon Islands”
or “Sao Tome” or Senegal or “Sierra Leone” or Somalia or Su-
dan or Tajikistan or Tanzania or Timor or Togo or Uganda or
Uzbekistan or Vietnam or “Viet Nam” or Yemen or Zambia
or Zimbabwe )
S26 MW ( Albania or Algeria or Angola or Armenia or Azerbaijan
or Belarus or Bhutan or Bolivia or Bosnia or Herzegovina or
“Cape Verde” or Cameroon or China or Colombia or Congo
or Cuba or Djibouti or “Dominican Republic” or Ecuador or
Egypt or “El Salvador” or Fiji or Gaza or Georgia or Guam
or Guatemala or Guyana or Honduras or “Indian Ocean Is-
lands” or Indonesia or Iran or Iraq or Jamaica or Jordan or
Kiribati or Lesotho or Macedonia or Maldives or “Marshall
Islands” or Micronesia or “Middle East” or Moldova or Mo-
rocco or Namibia or Nicaragua or Palestin* or Paraguay or
Peru or Philippines or Samoa or “Sri Lanka” or Suriname or
Swaziland or Syria or “Syrian Arab Republic” or Thailand or
Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu or
“West Bank” ) or TI ( Albania or Algeria or Angola or Arme-
nia or Azerbaijan or Belarus or Bhutan or Bolivia or Bosnia
or Herzegovina or “Cape Verde” or Cameroon or China or
Colombia or Congo or Cuba or Djibouti or “Dominican Re-
public” or Ecuador or Egypt or “El Salvador” or Fiji or Gaza
or Georgia or Guam or Guatemala or Guyana or Honduras or
“Indian Ocean Islands” or Indonesia or Iran or Iraq or Jamaica
or Jordan or Kiribati or Lesotho or Macedonia or Maldives or
“Marshall Islands” orMicronesia or “Middle East” orMoldova
or Morocco or Namibia or Nicaragua or Palestin* or Paraguay
or Peru or Philippines or Samoa or “Sri Lanka” or Suriname
or Swaziland or Syria or “Syrian Arab Republic” or Thailand
or Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu
or “West Bank” ) or AB ( Albania or Algeria or Angola or Ar-
menia or Azerbaijan or Belarus or Bhutan or Bolivia or Bosnia
or Herzegovina or “Cape Verde” or Cameroon or China or
Colombia or Congo or Cuba or Djibouti or “Dominican Re-
public” or Ecuador or Egypt or “El Salvador” or Fiji or Gaza
or Georgia or Guam or Guatemala or Guyana or Honduras or
“Indian Ocean Islands” or Indonesia or Iran or Iraq or Jamaica
or Jordan or Kiribati or Lesotho or Macedonia or Maldives or
“Marshall Islands” orMicronesia or “Middle East” orMoldova
or Morocco or Namibia or Nicaragua or Palestin* or Paraguay
or Peru or Philippines or Samoa or “Sri Lanka” or Suriname
or Swaziland or Syria or “Syrian Arab Republic” or Thailand
or Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu
or “West Bank” )
52,828
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S25 MW ( “American Samoa” or Argentina or Belize or Botswana
or Brazil or Brasil or Bulgaria or Chile or Comoros or “Costa
Rica” or Croatia or Dominica or Guinea or Gabon or Grenada
orGrenadines orHungary or Kazakhstan or Latvia or Lebanon
or Libia or libyan or Libya or Lithuania or Malaysia or Mau-
ritius or Mayotte or Mexico or Micronesia or Montenegro or
Nevis or “Northern Mariana Islands” or Oman or Palau or
Panama or Poland or Romania or Russia or “Russian Federa-
tion” or Samoa or “Saint Lucia” or “St Lucia” or “Saint Kitts”
or “St Kitts” or “Saint Vincent” or “St Vincent” or Serbia or
Seychelles or Slovakia or “Slovak Republic” or “South Africa”
or Turkey or Uruguay or Venezuela or Yugoslavia ) or TI (
“AmericanSamoa” orArgentina orBelize or Botswana orBrazil
or Bulgaria or Chile or Comoros or “Costa Rica” or Croatia or
Dominica or Guinea or Gabon or Grenada or Grenadines or
Hungary or Kazakhstan or Latvia or Lebanon or Libia or libyan
or Libya or Lithuania or Malaysia or Mauritius or Mayotte or
Mexico or Micronesia or Montenegro or Nevis or “Northern
Mariana Islands” or Oman or Palau or Panama or Poland or
Romania or Russia or “Russian Federation” or Samoa or “Saint
Lucia” or “St Lucia” or “Saint Kitts” or “St Kitts” or “Saint
Vincent” or “St Vincent” or Serbia or Seychelles or Slovakia
or “Slovak Republic” or “South Africa” or Turkey or Uruguay
or Venezuela or Yugoslavia ) or AB ( “American Samoa” or Ar-
gentina or Belize or Botswana or Brazil or Bulgaria or Chile or
Comoros or “Costa Rica” orCroatia orDominica orGuinea or
Gabon or Grenada or Grenadines or Hungary or Kazakhstan
or Latvia or Lebanon or Libia or libyan or Libya or Lithuania
or Malaysia or Mauritius or Mayotte or Mexico or Microne-
sia or Montenegro or Nevis or “Northern Mariana Islands” or
Oman or Palau or Panama or Poland or Romania or Russia or
“Russian Federation” or Samoa or “Saint Lucia” or “St Lucia”
or “Saint Kitts” or “St Kitts” or “Saint Vincent” or “St Vin-
cent” or Serbia or Seychelles or Slovakia or “Slovak Republic”
or “South Africa” or Turkey or Uruguay or Venezuela or Yu-
goslavia )
62,809
S24 TI ( Africa or Asia or “South America” or “Latin America” or
“Central America” ) or AB ( Africa or Asia or “South America”
or “Latin America” or “Central America” )
14,134
S23 (MH “Asia+”) 99,994
S22 (MH “West Indies+”) 5,217
S21 (MH “South America+”) 25,838
S20 (MH “Latin America”) 1,323
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S19 (MH “Central America+”) 2,168
S18 (MH “Africa+”) 32,362
S17 (MH “Developing Countries”) 8,973
S16 S13 OR S14 OR S15 8,805
S15 TI (immunization or immunisation or vaccination) W0 (pro-
gram* or rate* or coverage or adher*)
1,249
S14 TI ( (vaccinat* or revaccinat* or immunization or immunisa-
tion) N3 (child* or infant or infants or newborn or neonat* or
baby or babies or kid or kids or toddler* or woman or women
or mother*) ) OR AB ( (vaccinat* or revaccinat* or immuniza-
tion or immunisation) N3 (child* or infant or infants or new-
born or neonat* or baby or babies or kid or kids or toddler*
or woman or women or mother*) )
3,345
S13 S5 AND S12 6,586
S12 S6 OR S7 OR S8 OR S9 OR S10 OR S11 320,243
S11 (MH “Expectant Mothers”) 2,193
S10 (MH “Women”) 11,013
S9 (MH “Mothers”) 13,932
S8 (MH “Infant, Newborn”) 65,336
S7 (MH “Infant”) 83,244
S6 (MH “Child”) 220,709
S5 S1 or S2 or S3 or S4 18,740
S4 (MH “Immunization Programs”) 3,081
S3 (MH “Immunotherapy”) 2,729
S2 (MH “Immunization Schedule”) 1,940
S1 (MH “Immunization”) 12,688
EMBASE (Ovid)
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# Searches Results
1 Immunization/ 75,652
2 Active Immunization/ 6595
3 Mass Immunization/ 2421
4 Vaccination/ 96,045
5 Revaccination/ 1059
6 (vaccinat$ or revaccinat$ or immunization or immunisation
or immunotherapy).tw
226,888
7 or/1-6 289,620
8 Tetanus Prophylaxis/ 1259
9 BCG Vaccination/ 7072
10 Measles Vaccination/ 2189
11 or/8-10 10,339
12 Tetanus Toxoid/ 10,548
13 Diphtheria Toxoid/ 2535
14 Diphtheria Toxoid crm197/ 216
15 Diphtheria Tetanus Toxoid/ 427
16 BCG Vaccine/ 27,645
17 Diphtheria Pertussis Poliomyelitis Tetanus Haemophilus In-
fluenzae Type B Hepatitis B Vaccine/
380
18 Diphtheria Pertussis Poliomyelitis Tetanus Vaccine/ 393
19 Diphtheria Pertussis Tetanus Haemophilus Influenzae Type B
Hepatitis B Vaccine/
158
20 Diphtheria Pertussis Tetanus Haemophilus Influenzae Type B
Vaccine/
464
21 Diphtheria Pertussis Tetanus Vaccine/ 6524
22 Diphtheria Poliomyelitis Tetanus Vaccine/ 74
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23 Diphtheria Tetanus Vaccine/ 675
24 Diphtheria Vaccine/ 1902
25 Haemophilus Influenzae Type B Hepatitis B Vaccine/ 230
26 Haemophilus Influenzae Type B Vaccine/ 4269
27 Haemophilus Influenzae Vaccine/ 944
28 Haemophilus Vaccine/ 764
29 Pertussis Vaccine/ 6378
30 Triple Vaccine/ 715
31 Hepatitis a Hepatitis B Vaccine/ 502
32 Hepatitis B Vaccine/ 15,773
33 Hepatitis Vaccine/ 2126
34 Recombinant Hepatitis B Vaccine/ 1776
35 Measles Mumps Rubella Vaccine/ 5594
36 Measles Mumps Vaccine/ 102
37 Measles Rubella Vaccine/ 100
38 Measles Vaccine/ 7860
39 Mumps Vaccine/ 2031
40 Rubella Vaccine/ 3477
41 Chickenpox Measles Mumps Rubella Vaccine/ 219
42 Poliomyelitis Vaccine/ 7207
43 Oral Poliomyelitis Vaccine/ 4250
44 ((tetanus or diphtheria) adj toxoid).tw. 5484
45 ((tetanus or diphtheria? or pertussis or whooping cough or
measles or mumps or rubella? or rubeola or mmr or polio$ or
tuberculosis or tuberculoses or bcg or calmette$ or hepatitis b
17,760
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or haemophilus or triple) adj vaccine?).tw
46 or/12-45 86,597
47 Tetanus/ 12,351
48 Diphtheria/ 9102
49 Measles/ 15,582
50 Mumps/ 5967
51 Rubella/ 9019
52 Pertussis/ 10,521
53 Poliomyelitis/ 18,525
54 Tuberculosis/ 89,886
55 Lung Tuberculosis/ 63,542
56 Mycobacterium Tuberculosis/ 48,597
57 Hepatitis B/ 69,010
58 Chronic Hepatitis/ 21,541
59 Haemophilus Influenzae/ 18,964
60 Haemophilus Influenzae Type B/ 3868
61 (tetanus or diphtheria? or measles or rubella? or rubeola or
mumps or epidemic parotit$ or pertussis or whooping cough
or polio$ or infantile paralysis or tuberculosis or tuberculoses
or hepatitis b or haemophilus influenza?).tw
333,094
62 or/47-61 440,846
63 exp Child/ 2,005,016
64 exp Newborn/ 450,384
65 Child Care/ 30,274
66 (child$ or infant? or newborn? or neonat$ or baby or babies
or kid? or toddler?).tw
1,614,491
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67 or/63-66 2,499,583
68 7 and (Tetanus/ or tetanus.tw.) 10,450
69 Tetanus Toxoid/ or Tetanus Prophylaxis/ or (tetanus toxoid or
tetanus vaccin$ or tetanus prophylaxis).tw
13,141
70 or/68-69 18,159
71 exp Mother/ 86,127
72 Female/ 5,983,316
73 (woman or women or mother? or female?).tw. 1,819,414
74 or/71-73 6,295,611
75 70 and 74 5326
76 Developing Country.sh. 75,918
77 (Africa or Asia or Caribbean or West Indies or South America
or Latin America or Central America).hw,ti,ab,cp
227,844
78 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brazil or Brasil or Bulgaria or
Burkina Faso or Burkina Fasso or Upper Volta or Burundi or
Urundi or Cambodia or Khmer Republic or Kampuchea or
Cameroon or Cameroons or Cameron or Camerons or Cape
Verde or Central African Republic or Chad or Chile or China
or Colombia or Comoros or Comoro Islands or Comores or
Mayotte or Congo or Zaire or Costa Rica or Cote d’Ivoire or
Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia
or Czech Republic or Slovakia or Slovak Republic or Djibouti
or French Somaliland or Dominica or Dominican Republic
or East Timor or East Timur or Timor Leste or Ecuador or
Egypt or United Arab Republic or El Salvador or Eritrea or
Estonia or Ethiopia or Fiji or Gabon or Gabonese Republic or
Gambia or Gaza or Georgia Republic or Georgian Republic
or Ghana or Gold Coast or Greece or Grenada or Guatemala
or Guinea or Guam or Guiana or Guyana or Haiti or Hon-
duras or Hungary or India or Maldives or Indonesia or Iran
or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan or
Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzs-
2,838,905
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tan or Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan
or Lao PDR or Laos or Latvia or Lebanon or Lesotho or Ba-
sutoland or Liberia or Libya or Lithuania or Macedonia or
Madagascar or Malagasy Republic or Malaysia or Malaya or
Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali
or Malta or Marshall Islands or Mauritania or Mauritius or
Agalega Islands or Mexico or Micronesia or Middle East or
Moldova or Moldovia or Moldovian or Mongolia or Mon-
tenegro or Morocco or Ifni or Mozambique or Myanmar or
Myanma or Burma or Namibia or Nepal or Netherlands An-
tilles or New Caledonia or Nicaragua or Niger or Nigeria or
Northern Mariana Islands or Oman or Muscat or Pakistan or
Palau or Palestine or Panama or Paraguay or Peru or Philip-
pines or Philipines or Phillipines or Phillippines or Poland or
Portugal or Puerto Rico or Romania or Rumania or Roumania
or Russia or Russian or Rwanda or Ruanda or Saint Kitts or St
Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St
Vincent or Grenadines or Samoa or Samoan Islands or Navi-
gator Island or Navigator Islands or Sao Tome or Saudi Ara-
bia or Senegal or Serbia or Montenegro or Seychelles or Sierra
Leone or Slovenia or Sri Lanka or Ceylon or Solomon Islands
or Somalia or Sudan or Suriname or Surinam or Swaziland or
Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or
Tanzania or Thailand or Togo or Togolese Republic or Tonga
or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan
or Turkmen or Uganda or Ukraine or Uruguay or USSR or
Soviet Union or Union of Soviet Socialist Republics or Uzbek-
istan or Uzbek or Vanuatu or New Hebrides or Venezuela or
Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia
or Zambia or Zimbabwe or Rhodesia).hw,ti,ab,cp
79 ((developing or less* developed or under developed or under-
developed or middle income or low* income or underserved
or under served or deprived or poor*) adj (countr* or nation?
or population? or world)).ti,ab
68,123
80 ((developing or less* developed or under developed or under-
developed or middle income or low* income) adj (economy
or economies)).ti,ab
351
81 (low* adj (gdp or gnp or gross domestic or gross national)).ti,
ab
187
82 (low adj3 middle adj3 countr*).ti,ab. 4139
83 (lmic or lmics or third world or lami countr*).ti,ab. 3741
84 transitional countr*.ti,ab. 138
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85 or/76-84 3,019,888
86 Randomized Controlled Trial/ 348,266
87 Controlled Clinical Trial/ 386,406
88 Quasi Experimental Study/ 2013
89 Pretest Posttest Control Group Design/ 206
90 Time Series Analysis/ 14,239
91 Experimental Design/ 10,019
92 Multicenter Study/ 109,759
93 (randomis* or randomiz* or randomly or random allocat*).ti,
ab
727,521
94 groups.ab. 1,698,086
95 (trial or multicentre or multicenter or multi centre or multi
center).ti
192,503
96 (intervention* or controlled or control group or compare or
compared or (before adj5 after) or (pre adj5 post) or pretest or
pre test or posttest or post test or quasiexperiment* or quasi
experiment* or evaluat* or effect or impact or time series or
time point? or repeated measur*).ti,ab
8,028,793
97 or/86-96 8,766,538
98 (systematic review or literature review).ti. 62,313
99 “cochrane database of systematic reviews”.jn. 3777
100 Nonhuman/ 4,359,920
101 or/98-100 4,424,301
102 97 not 101 6,927,465
103 7 and 62 and 67 and 85 and 102 4433
104 11 and 67 and 85 and 102 865
105 46 and 67 and 85 and 102 4231
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106 103 or 104 or 105 5462
107 limit 106 to embase 4043
Sociological Abstracts (ProQuest)
ALL(vaccination or vaccine or vaccines or immunization)
AND
ALL(child* or infant* or newborn or neonat* or baby or babies or kid or kids or toddler* or mother* or woman or women or female)
LILACS (VHL)
(immunization or inmunizacion or imunizacao or vaccination or vacunacion or vacinacao or vaccine or vaccines or vacuna or vacunas
or vacina or vacinas) AND (tetanus or tetanico or diphtheria or difterico or pertussis or “whooping cough” or tosferina or “tos ferina”
or “tos convulsa” or “tosse convulsa” or coqueluche or measles or sarampion or sarampo or mumps or paperas or caxumba or rubella
or rubeola or mmr or polio* or tubercul* or “mycobacterium bovis” or bcg or calmette* or hepatitis or hepatite or haemophilus) AND
(child or children or infant or infants or newborn or neonat* or baby or babies or kid or kids or toddler* or nino or ninos or crianca
or criancas or lactante* or lactente* or “recien nacido” or “recien nacidos” or “recem nascido” or “recem nascidos”) AND (randomi*
or randomly or azar or acaso or control* or intervention* or evaluat* or effect* or impact or impacts or intervencion* or intervencao*
or evaluar or evaluacion or avaliacao or efecto or efectos or efeito or efeitos or impacto or impactos or “serie de tiempo” or “series de
tiempo” or “serie de tempo” or “series de tempo” or “serie temporal” or “series temporal” or “serie temporales” or “series temporales”
or “serie temporais” or “series temporais” or “puntos de tiempo” or “pontos de tiempo” or “puntos de tempo” or “puntos de tempo” or
“puntos temporales” or “pontos temporales” or “punto temporais” or “ponto temporais” or “medida repetida” or “medida repetidas”
or “medidas repetida” or “medidas repetidas” or “medicion repetida” or “medicion repetidas” or “mediciones repetida” or “mediciones
repetidas”)
WH A T ’ S N E W
Last assessed as up-to-date: 5 July 2016.
Date Event Description
22 June 2016 New citation required and conclusions have changed Eight new studies were added to this update and the conclu-
sions have changed
22 June 2016 New search has been performed This is the first update of the Cochrane review published
in 2011. We conducted a new search and updated other
content. New authors were also added
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C O N T R I B U T I O N S O F A U T H O R S
AO: screening, data extraction, analysis, and write up.
CW: screening, data extraction, analysis, and write up.
CO: screening and data extraction.
CN: screening.
OO: screening.
MM: review of the update.
All authors read and approved the final version for submission.
D E C L A R A T I O N S O F I N T E R E S T
Angela Oyo-Ita: none known.
Charles S Wiysonge: none known.
Chioma Oringanje: none known.
Chukwuemeka E Nwachukwu: none known.
Olabisi Oduwole: none known.
Martin M Meremikwu: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Vaccines for Africa Initiative, University of Cape Town (CW), South Africa.
External sources
• Norwegian Agency for Development Cooperation (Norad), Norway.
• Research Council of Norway, Norway.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have changed the first primary outcome from ’Number of children aged two years fully immunised per vaccine’ in the previous
version of this review to the first primary outcome ’Proportion of children who received DTP3 by one year of age’ in this present review.
The latter is a widely accepted standard measure of a childhood immunisation programme’s ability to reach the target population.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Developing Countries; ∗Health Education; Immunization [∗utilization]; Motivation; Randomized Controlled Trials as Topic; Reward
MeSH check words
Humans; Infant; Infant, Newborn
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